First Spontaneous Combustion Death Reported In Ireland

An Irish coroner has ruled that a 76-year-old man who burned to death last December was a victim of spontaneous combustion, according to BBC News reports on Friday.

Dr. Ciaran McLoughlin, the coroner of West Galway, said that the death of Michael Faherty was the first case of spontaneous combustion he had ever seen. Faherty died at his home in Clareview Park, Ballybane, on December 22, 2010, and according to the British news agency, “investigators had been baffled as to the cause of Mr. Faherty’s death.”

“Forensic experts found that a fire in the fireplace of the sitting room where the badly burnt body was found, had not been the cause of the blaze that killed Mr. Faherty,” the BBC said in a September 23 report. “The court was told that no trace of an accelerant had been found and there had been nothing to suggest foul play.”

Furthermore, the court was told that Faherty had been found on his back, with his head close to an open fireplace. The only things damaged by the fire were his body, which the BBC described as “totally burnt,” the floor beneath him and the ceiling above him.

“This fire was thoroughly investigated and I’m left with the conclusion that this fits into the category of spontaneous human combustion, for which there is no adequate explanation,” McLoughlin told the UK media outlet.

While the idea of spontaneous combustion is not a new one, it largely has been the stuff of myths and legends. However, according to Lucy Burton of the Telegraph, in 1998, forensic scientists believed that the discovered a possible reason why such an event might occur.

According to Burton, the BBC program QED “brought together the world´s top fire experts to investigate the alleged ‘wick effect’. The team used a dead pig wrapped in cloth to test the idea that a body can be devoured by flames from its own body fat.”

“The scientists found that clothing can soak up melted fat and act like the wick of a candle, leaving surrounding materials unharmed,” she added. “This would explain one of the key characteristics of SHC deaths — the victim’s furniture is usually left untouched.”

The Daily Mail reports that this is believed to be the first reported fatality as a result of spontaneous human combustion in the history of Ireland. The newspaper added that Faherty’s daughter, Mairin, accepted the results of the investigation and was “satisfied” by the findings.

On the Net:

Hospital Curtains Potential Source of Deadly Bacteria

Hospital privacy curtains are frequently sources of infectious, potentially dangerous bacteria, researchers said at an infectious diseases conference in Chicago earlier this week.

In research presented Monday during the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy on Monday, Dr. Michael Ohl of the University of Iowa and colleagues swabbed 43 hospital curtains two times a week for a period of three weeks.

According to Reuters reporter Fran Lowry, Ohl’s team looked at a total of 180 samples and found germs on 119 of them. Furthermore, Lowry wrote on Thursday, 26% of them tested positive for the “potentially deadly antibiotic-resistant Staphylococcus aureus bacteria known as MRSA,” while 44% contained some form of antibiotic-resistant Enterococcus bacteria.

In addition, the researchers put 13 new curtains in a hospital as part of the study. Within one week’s time, all but one of them had become contaminated, Reuters reported. A total of 41 of 43 curtains analyzed had been contaminated at least once during the course of the study.

“There is growing recognition that the hospital environment plays an important role in the transmission of infections in the health care setting and it’s clear that these (privacy curtains) are potentially important sites of contamination because they are frequently touched by patients and providers,” Dr. Ohl told Lowry.

“The vast majority of curtains showed contamination with potentially significant bacteria within a week of first being hung, and many were hanging for longer than three or four weeks,” he added. “We need to think about strategies to reduce the potential transfer of bacteria from curtains to patients.”

Among the strategies he suggests are for health care professionals to wash their hands after pulling the curtain and before interacting with their patient, as well as disinfecting on a more frequent basis.

In an email sent to CBS News, Dr. Robert Glatter, and editorial board member for Medscape Emergency Medicine, said that patients “should not be intimidated or afraid to ask doctors if they washed their hands after noticing the provider touched a medical curtain.”

On the Net:

21st Century Vaccines — Innovation In Design And Rational Use

Holds great promise for global public health

Innovation in the design of vaccines is rapidly expanding their use, safety, and effectiveness for disease prevention and therapeutic interventions. The enormous potential of OMICS sciences for global health and vaccine design is examined in “Vaccines of the 21st Century and Vaccinomics,” a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed journal published by Mary Ann Liebert, Inc. The issue is available free online.

“Truly a fresh new look at how we design vaccines and apply them judiciously to benefit global health is essential and timely in the present age of data enabled science and postgenomics integrative biology,” writes Eugene Kolker, PhD, Editor-in-Chief of OMICS, and Chief Data Officer, Seattle Children’s Hospital, and Head, Bioinformatics & High-Throughput Analysis Laboratory, Seattle Children’s Research Institute, and the Special Issue Guest Editor Vural Ozdemir (Associate Professor, McGill University, Canada), and co-authors of the Introductory Editorial, Tikki Pang (World Health Organization, Geneva, Switzerland), Bartha M. Knoppers, Denise Avard, Ma’n H. Zawati (Centre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine, McGill University), and Samer A. Faraj (Desautels Faculty of Management, McGill University).

Despite advances in public health in the 21th century, we still lack safe and highly effective vaccines against the common pathogens seriously affecting global society such as neglected tropical diseases and helminth infections, tuberculosis, HIV, and malaria. These gaps in global health are deepened further by the lack of development of new antimicrobial drugs. The new field of vaccinomics relies on the integrated use of multi-omics data intensive biotechnologies (e.g., genomics, proteomics, metabolomics) to understand individual and population differences in immune responses to vaccines. Vaccinomics holds great promise for the design of safer and more effective vaccines, and their targeted rational use via novel postgenomics diagnostics to prevent and combat infectious diseases, and to intervene in chronic non-communicable diseases such as cancer, diabetes, and obesity.

Featuring global contributions from leading experts in Australia, Asia, Europe, and North America, “Vaccines of the 21st Century: Vaccinomics for Global Public Health” includes a series of articles on cutting-edge topics such as the conceptual basis of vaccinomics; high throughput ”game changing” experimental approaches for 21st century vaccine design; case studies including previously neglected tropical diseases vastly affecting the developing countries (e.g., vaccinomics for helminth infections); the new therapeutic cancer vaccines; social science and policy analyses on vaccinomics and global health convergence, and the current strategies for vaccinomics-enabled rational vaccine design deployed by the vaccine industry.

An opinion piece by Alan Bernstein, Global HIV Vaccine Enterprise (New York, NY), Bali Pulendran, Emory University School of Medicine (Atlanta, GA), and Rino Rappuoli, Novartis Global Vaccines and Diagnostics (Siena, Italy) provides a forward look in the article “Systems Vaccinomics: The Road Ahead for Vaccinology.”

Guest Editor Vural Ozdemir notes that “OMICS technologies and postgenomics diagnostics, when considered under a sound public health genomics framework, can offer innovative and potentially cost-effective solutions to current priorities in global health.” In a concluding remark, he observes that the new science demands more than technological proficiency: “Seeking science-based solutions such as vaccinomics for the extant global public health priorities can only be achieved in a sustainable manner through a tri-partite integration of the biological, social, and political determinants of health.”

On the Net:

FDA To Phase Out Some Primatene Asthma Inhalers

 

An over-the-counter asthma inhaler is to be banned beginning next year because federal health officials said it produces carbon gas that is harmful to the environment, Reuters reports.

The inhaler in question is currently the only over-the-counter inhaler on the market, which when banned, will leave asthma patients with only prescription-based choices.

The Food and Drug Administration said on Thursday that chlorofluorocarbons (CFCs) in the metered-dose inhalers that contain epinephrine will be taken off the market after an international agreement was struck to ban all CFC products because they deplete the Earth´s ozone.

The inhaler, called Primatene Mist, marketed by Armstrong Pharmaceuticals, is used to temporarily relieve occasional symptoms of mild asthma, and has been the only FDA-approved over-the-counter inhaler available without a prescription, the FDA said in a statement.

The FDA first proposed phasing out CFCs in asthma inhalers in 2006, and finalized the phase-out in 2008. Most inhaler manufacturers have switched to using hydrofluoroalkane as a propellant. These inhalers treat the same asthma symptoms but are only available with a prescription.

Primatene Mist inhalers are now labeled with a notice saying they cannot be used after December 31, 2011. The prescription alternative will be more costly, but also more eco-friendly.

One million to 2 million patients in the US still use Primatene Mist. The FDA said that it is difficult to get an accurate estimate of how many people use over-the-counter drugs.

Asthma is the most common chronic disease in children in the world. In all, more than 235 million people suffer from asthma worldwide, according to the World Health Organization.

Two prescription-based inhalers — Boehringer Ingelheim´s Combivent Inhalation Aerosol and Graceway Pharmaceuticals Maxair Autohaler — that use CFCs will be phased out by the end of 2013.

The US began phasing out CFCs used in consumer products back in 1978, but the FDA allowed most medical products to continue to use them.

On the Net:

Stimulant May Speed up Recovery from Anesthesia

(Ivanhoe Newswire) — Administering Ritalin, a commonly used stimulant, to patients recovering from anesthesia sped up the process. This study is the first to demonstrate in mammals what could be a safe and effective way to induce arousal from general anesthesia.

“Currently at the end of a surgical procedure, the anesthesiologist just lets general anesthetic drugs wear off, and the patient regains consciousness,” Emery Brown, MD, PhD, of the MGH Department of Anesthesia, Critical Care and Pain Medicine, senior author of the paper, was quoted as saying. “If these findings can be replicated in humans, it could change the practice of anesthesiology — potentially reducing post-anesthesia complications like delirium and cognitive dysfunction in pediatric and elderly patients.”

General anesthesia has been an essential tool of medicine, but only in recent years have researchers begun to investigate the neurobiology of general anesthesia and to understand exactly how anesthetic drugs produce their effects. Studies by Brown and other scientists have shown that the state of general anesthesia is actually a controlled and reversible coma and bears little similarity to natural sleep. Several neurotransmitter pathways in the brain are known to be generally involved in arousal, but which ones may contribute to recovery from general anesthesia is not yet known.

The stimulant drug methylphenidate (Ritalin), widely used to treat attention-deficit hyperactivity disorder, is known to affect arousal-associated pathways controlled by the neurotransmitters dopamine, norepinephrine and histamine. The current study was designed to see whether methylphenidate could stimulate arousal in rats receiving the anesthetic drug isoflurane. The first experiments showed that animals receiving intravenous methylphenidate five minutes before discontinuation of isoflurane recovered significantly faster than did rats receiving a saline injection. Another experiment showed that methylphenidate induced signs of arousal — movement, standing up, etc. — in animals continuing to receive isoflurane at a dose that would have been sufficient to maintain unconsciousness. EEG readings taken during that experiment showed that brain rhythms associated with arousal returned within 30 seconds of methylphenidate administration. Giving a drug that interferes with the dopamine pathway blocked the arousal effects of methylphenidate, supporting the role of that pathway in the drug’s effects.

“Our results tell us that, even though we don’t yet know the precise mechanisms underlying general anesthesia, we can overcome its effects by activating arousal pathways,” Ken Solt, MD, of the MGH Department of Anesthesia, Critical Care and Pain Medicine, the paper’s lead and corresponding author, was quoted as saying. “Instead of the traditional paradigm of reversing drug actions at the molecular level, methylphenidate acts at the level of neural circuits to overcome the effects of isoflurane. Since we still know very little about the pathways involved in general anesthesia, we will be testing the actions of methylphenidate with other anesthetic agents to see if these arousal effects are broadly applicable.”

SOURCE: Anesthesia, published online September 21, 2011

Ritalin May Help Wake Up The Brain After Surgery

 

New research in the journal Anesthesiology shows that Ritalin, given to anesthetized rats, allows them to come around quicker than those not given the stimulant.

Dr. Emory Brown, a professor in the Department of Brain and Cognitive Sciences and the Harvard-MIT Division of Health Sciences and Technology says, “It´s like giving a shot of adrenaline to the brain.”

According to an MIT press release, there are currently no drugs to aid patients in coming out of anesthesia. The anesthetist just stops giving the patient the drugs and when the drugs wear off the patient is typically groggy for hours.

Dr. Brown said in the press release” “Our thought is you should try to do things to clear up your head as quickly as possible. The objective should be the return, as soon as possible, to the level at which the patient was before the operation.”

Dr. Brown notes that it is important for patients to return to a clear headed state quickly. It would allow them to make important decisions soon after their operations, instead of waiting for hours after the operation is completed. He also says that because of the expense in operating room costs, cutting down on the recovery time would help the patient to recoup some of the expense because extra time adds up quickly. At Massachusetts General Hospital, where Dr. Brown practices, operating room costs from $1000 to $1500 per hour.

Ritalin is the chosen drug in the study because it has already been approved for use by the FDA to treat Attention Deficit Hyperactivity Disorder and will be easier to approve for this use, instead of inventing a new drug.

According to the press release, when Ritalin enters the brain, it increases the amount of dopamine available in the brain´s cortex. This effect sharpens the focus of ADHD patients and may have a similar effect on patients given anesthesia. Dr. Zhang Xie, who was not involved in the study, says that this is a significant finding, and that it might also be possible to design new drugs that act in similar fashion without the side effects that some patients endure with Ritalin, such as hypertension, hyperventilation and nausea.

On the Net:

Have CERN Experiments Broken The Speed Of Light?

 

Researchers at the European Centre for Nuclear Research (CERN) are reporting that they have discovered sub-atomic particles moving faster than the speed of light — a finding which, if verified, could well turn the fundamental laws of the universe on their ear.

According to various media reports Thursday, the experiment responsible for the discovery involved sending 15,000 beams of tiny particles known as neutrinos from the CERN laboratory near Geneva, Switzerland to the Gran Sasso facility in Italy some 500 miles (730 km) away.

The neutrinos were fired over a period of three years, and reportedly arrived at their destination 60 nanoseconds, or 60 billionths of a second, more quickly than light beams would have.

If those results can be confirmed, it would be inconsistent with Albert Einstein’s theory of special relativity. According to that 1905 theory, the speed of light is a “cosmic constant,” and that there is nothing in the universe that can travel faster.

That assertion has, according to the Telegraph, withstood more than a century of testing and remains one of the pillars of the Standard Model of physics, “which attempts to describe the way the universe and everything in it works.”

“This result comes as a complete surprise,” Antonio Ereditato, a physicist and the spokesman for the Oscillation Project with Emulsion-tRacking Apparatus or OPERA experiment, told the AFP. “We wanted to measure the speed of neutrinos, but we didn’t expect to find anything special.”

The team reported that they spent approximately half a year “checking, testing, controlling and rechecking everything” before making a public announcement, he told the news agency.

“We have high confidence in our results. We have checked and rechecked for anything that could have distorted our measurements but we found nothing,” he added, in a separate interview with the Telegraph. “We now want colleagues to check them independently.”

What that will entail, according to what CERN spokesman James Gilles told Frank Jordans and Seth Borenstein of the Associated Press (AP), is asking other scientists to review and, if possible, repeat the measurements. Researchers at Chicago-based Fermilab (who in 2007 had recorded similar findings but “with a giant margin of error that undercut its scientific significance,” according to the AP) told Jordans and Borenstein that they planned to begin such work in the near future.

“We tried to find all possible explanations for this,” Ereditato explained to BBC News Science and Technology Reporter Jason Palmer. “We wanted to find a mistake — trivial mistakes, more complicated mistakes, or nasty effects — and we didn’t“¦ When you don’t find anything, then you say ‘Well, now I’m forced to go out and ask the community to scrutinize this.'”

The discovery, according to Robert Evans of Reuters, could blur the lines between science and science fiction. After all, as Evans wrote on Thursday, “if the light-speed barrier can be overcome, time travel might theoretically become possible.”

On the Net:

Science Museum To Digitize Babbage’s Analytical Engine

 
A project to build British mathematician Charles Babbage’s mechanical computer has just earned assistance from the Science Museum in London, who will begin digitizing Babbage´s original plans and notebooks.
The images will ultimately be used by John Graham-Cumming, the programmer and computer historian behind the project, dubbed Plan 28, to create a full working model of the Analytical Engine.
Charles Babbage (1791-1871) is widely regarded as the inventor of computing.  His Analytical Engine, conceived in the late 1830s, predated the modern computer revolution by more than a hundred years.
Babbage´s notebooks and designs are currently held in the Science Museum’s archives, but have never been translated into an easily accessible format.
Scientists hope digital documents will allow researchers around the world to analyze Babbage´s many disparate ideas, and determine the definitive version of the machine.
“There are some complete plans, they are just not totally complete. There will be a degree of interpretation,” Graham-Cumming told BBC news.
After a period of study, a computer simulation of the Analytical Engine would be produced before its eventual construction, he added.
“The machine itself is going to be enormous, about the size of a small steam train, so the simulation is important to allow anyone access,” he said.
Doron Swade, the Science Museum’s former curator of computing, is another key figure in the push to build the Analytical Engine. Swade led the initiative to build Babbage’s earlier design, known as the Difference Engine No.2, which was essentially an early calculator.
The Difference Engine was less sophisticated than the Analytical Engine, which is closer to a complete computer, with punched card input and processing by its rotating mechanical barrels and output to a printer, plotter or ringing bell.
Mr. Graham-Cumming said it was possible to make some rough estimates of Analytical Engine’s processing power. 
Its memory would be equivalent to roughly 675bytes, slightly more than half that of Sinclair’s ZX81, released in 1981, he said.  
A later proposal by Babbage called for 20KB of storage.
The machine’s clock speed would be about 7Hz, compared to the ZX81’s 3.2MHz. Current high-end microprocessors currently run at around 3GHz, although their modern architectures means they are exponentially more powerful.
“[The Analytical Engine] is actually quite fast given that it’s all in cogs, so Babbage was thinking about something relatively powerful. Of course, we’re far beyond that now,” Mr. Graham-Cumming told BBC News.
Although the project does not yet have a fixed timescale, it was unlikely to produce anything physical for “at least five years,” he said.
However, he has set the goal of completing it by 2021 – the 150th anniversary of Charles Babbage’s death.
The Science Museum began work on the digitization of Babbage’s notes on September 12, and the Plan 28 team expects to start studying them in early October.
“This great first step on Plan 28 is, finally, underway. We are very, very grateful to The Science Museum and all we have worked with there for their support and for having undertaken this vital work that will benefit not only Plan 28 but all those who wish to study Charles Babbage’s work wherever they are,” wrote Graham-Cumming in a posting to his blog this week.

Image Caption: Trial model of a part of the Analytical Engine, built by Babbage,[1] as displayed at the Science Museum (London). Credit: Bruno Barral/Wikipedia (CC-BY-SA-2.5)   

On the Net:

Genetic Mutation Linked To Lou Gehrig’s Disease And Dementia

  
Scientists have identified a new human genetic mutation that is responsible for the most common cause of Lou Gehrig’s disease and dementia.
The researchers performed a genetic analysis and determined that a genetic mutation in the gene C9ORF72 was found in almost 12 percent of all dementia patients in the study and over 22 percent in all amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease patients.
“This finding has the potential to lead to significant insights into how both of these neurodegenerative diseases develop, and may give us much needed leads into new ways to treat our patients,” senior investigator Rosa Rademakers, Ph.D., a neuroscientist at the Mayo Clinic campus in Florida, said in a press release.
Researchers have found similarities between both dementia and ALS patients.  Dementia is characterized by changes in personality, behavior and language due to loss of gray matter in the brains’ frontal lobe.  ALS destroys motor neuron cells that control muscle activity like speaking, walking, breathing and swelling.
Researchers have found that up to half of ALS patients experience symptoms of dementia and up to half of dementia patients develop symptoms seen in Lou Gehrig’s disease.
Bryan J. Traynor, M.D., an assistant professor in the Department of Neurology at the Johns Hopkins University School of Medicine, and colleagues used a genomic sequencing technique on pieces of chromosome 9 sampled from ALS and dementia patients.
They compared the sequences to healthy people outside of the participants’ families who had never been diagnosed with either condition.
A genetic mutation turned up in a section of chromosome 9 in the C9ORF72 gene in just the affected individuals. 
“If you think of chromosomes like geographic regions, we knew what city this mutation was located in, and what part of the city, but we didn’t know what street it was located on or which house,” Traynor said in a press release. “We were really looking for the exact address for this mutation.”
He said he and his colleagues do not know how the repeated segments might cause ALS and dementia, but it could cause affected cells to manufacture toxic genetic material that clogs up cells and eventually leads to their destruction.
“This finding has the potential to lead to significant insights into how both of these neurodegenerative diseases develop, and may give us much needed leads into new ways to treat our patients,” senior investigator Rosa Rademakers, Ph.D., a neuroscientist at the Mayo Clinic campus in Florida, said in a press release.
Two independent studies were published online regarding this discovery by Cell Press in the journal Neuron. 

On the Net:

Oral Calcitonin Tablet Safe for Treating Osteoporosis

(Ivanhoe Newswire) — OSTORA, a new oral drug made of salmon calcitonin, was in its third phase of study to determine if it effectively treated postmenopausal osteoporosis. The researchers deemed it safe and effective.
The ORACAL study was a Phase III multinational, randomized, double-blind, double-dummy, placebo-controlled trial of Tarsa’s oral recombinant salmon calcitonin compared to commercially available, synthetic salmon calcitonin administered by nasal spray and to placebo. The trial enrolled 565 postmenopausal women in six countries with established osteoporosis.
“These are encouraging results that may be of particular relevance for the women with osteoporosis who are reluctant to take or unable to tolerate currently available treatments,” Neil Binkley, MD, who is an Associate Professor of Endocrinology and Geriatrics at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin, was quoted as saying. “Potential safety issues with current drug therapies, while rare, have led some osteoporosis patients to discontinue therapy or avoid beginning treatment. Calcitonin has a long history of safety for postmenopausal osteoporosis treatment, and potential availability of this once-daily oral formulation could make it a useful new option for osteoporosis patients and their physicians.”
According to the International Osteoporosis Foundation, studies indicate that up to half of osteoporosis patients stop their treatment after just one year. In one study, two-thirds of osteoporosis patients said their medication interfered with their lives in some way and over 20% of the women who missed or stopped their treatment said it was due to side effects.
Calcitonin is approved for the treatment of postmenopausal osteoporosis, but its use has been limited by the fact that it is currently available only in intranasal and injectable forms. Prior clinical studies show that Tarsa’s oral calcitonin tablet delivers calcitonin effectively and reduces blood levels of bone resorption biomarkers.
“We view the new OSTORA data presented today as very promising news for osteoporosis patients and their physicians seeking additional treatment options,” David Brand, President and CEO of Tarsa, was quoted as saying. “We look forward to filing a New Drug Application for OSTORA with the Food and Drug Administration and to submitting a Marketing Authorization Application to the European Medicines Agency thereafter. We also are advancing our ongoing Phase Il trial in osteoporosis prevention, an indication for which our oral calcitonin could be especially relevant.”
SOURCE: American Society for Bone and Mineral Research 2011 Annual Meeting by ORACAL held in San Diego California from September 2011

Recession Linked To Increase In Child Abuse

 

According to new research from Childrens Hospital of Pittsburgh, the recession is linked to an increase in child abuse.

The researchers studied 422 abused children from lower-income families in 74 counties in four states.

Lead author Dr. Rachel Berger of the hospital said the results confirm anecdotal reports from many pediatricians who have seen increasing numbers of shaken baby cases and other forms of brain-injuring abuse.

She decided to study the type of injury after noticing an increase at her own hospital during the latest recession.

Berger said that her hospital averaged 30 shaken baby cases a year during late 2007 through June 2009, compared to 17 before 2007.

The study found that number of cases per county increased from 9 cases per 100,000 children in pre-recession years to 15 cases per 100,000 kids during the recession.

Most of the children who were studied suffered brain damage and 69 died. 

Mark Rank, a social welfare professor at Washington University in St. Louis, said in a statement to the Associated Press (AP) that with the stress of raising a young child combined with wage cuts or lost jobs, it results in “a sort of toxic brew in terms of thinking about possible physical violence.”

About 1,800 toddlers in the U.S. suffer from an abusive head trauma each year, but the researchers believe this statistic is an underestimate.

Federal data showed a decline in child abuse in 2008, but Berger said those numbers did not take shaken baby cases into account and have a restrictive definition of abuse.

Berger said one reason for the increase is that mothers may have had to leave their babies with people who do not usually take care of them.

“The number one perpetrators are fathers and male caretakers,” she said. “Very few perpetrators are mothers. It’s the people that mothers give their kids to that end up being the perpetrator.”

Dr. Peter Sherman, director of the residency program in social pediatrics at Montefiore Medical Center in New York, told AP that studying different regions and children from more middle class families would help clarify if the recession played a role.

Most parents who abuse young children aren’t “ill-intentioned,” he said in a statement. “Most of it is kind of just snapping…maybe being sleep-deprived and just losing it. It’s something that can happen to anyone. Economics is just another stress” that can increase the risks, Sherman said.

The study was published online in the journal Pediatrics.

On the Net:

Brightest Gamma Ray On Earth For A Safer, Healthier World

 

Ray more than a thousand billion times brighter than the sun

The brightest gamma ray beam ever created- more than a thousand billion times more brilliant than the sun- has been produced in research led at the University of Strathclyde- and could open up new possibilities for medicine.

Physicists have discovered that ultra-short duration laser pulses can interact with ionized gas to give off beams that are so intense they can pass through 20 cm of lead and would take 1.5 m of concrete to be completely absorbed.

The ray could have several uses, such as in medical imaging, radiotherapy and radioisotope production for PET (positron emission tomography) scanning. The source could also be useful in monitoring the integrity of stored nuclear waste.

In addition, the laser pulses are short enough- lasting a quadrillionth of a second- to capture the response of a nucleus to stimuli, making the rays ideal for use in lab-based study of the nucleus.

The device used in the research is smaller and less costly than more conventional sources of gamma rays, which are a form of X-rays.

The experiments were carried out on the Gemini laser in the Central Laser Facility at the Science and Technology Facilities Council’s Rutherford Appleton Laboratory. Strathclyde was also joined in the research by University of Glasgow and Instituto Superior Técnico in Lisbon.

Professor Dino Jaroszynski of Strathclyde, who led the research, said: “This is a great breakthrough, which could make the probing of very dense matter easier and more extensive, and so allow us to monitor nuclear fusion capsules imploding.

“To prove this we have imaged very thin wires – 25 microns thick – with gamma rays and produced very clear images using a new method called phase-contrast imaging. This allows very weakly absorbing material to be clearly imaged. Matter illuminated by gamma rays only cast a very weak shadow and therefore are invisible. Phase-contrast imaging is the only way to render these transparent objects visible.

“It could also act as a powerful tool in medicine for cancer therapy and there is nothing else to match the duration of the gamma ray pulses, which is also why it is so bright.

“In nature, if you accelerate charged particles, such as electrons, they radiate. We trapped particles in a cavity of ions trailing an intense laser pulse and accelerated these to high energies. Electrons in this cavity also interact with the laser and pick up energy from it and oscillate wildly – much like a child being pushed on a swing. The large swinging motion and the high energy of the electrons allow a huge increase in the photon energy to produce gamma rays. This enabled the gamma ray photons to outshine any other earthbound source.

“The accelerator we use is a new type called a laser-plasma wakefield accelerator which uses high power lasers and ionized gas to accelerate charged particles to very high energies – thus shrinking a conventional accelerator, which is 100m long, to one which fits in the palm of your hand.”

The peak brilliance of the gamma rays was measured to be greater than 1023 photons per second, per square milliradian, per square millimeter, per 0.1% bandwidth.

The research was supported by the Engineering and Physical Sciences Research Council, the Science and Technology Facilities Council, the Laserlab-Europe Consortium and the Extreme Light Infrastructure project. It is linked to SCAPA (Scottish Centre for the Application of Plasma-based Accelerators), which is based at Strathclyde and is run through the Scottish Universities Physics Alliance.

The research has been published in the journal Nature Physics.

Image 1: This is student and research associate Silvia Cipiccia of the University of Strathclyde. Credit: University of Strathclyde

Image 2: This is professor Dino Jaroszynski of the University of Strathclyde. Credit: University of Strathclyde

On the Net:

The High Cost Of Chronic Disease

 

A study conducted by the World Economic Forum (WEF) found that the cost of treating chronic or non-communicable diseases (NCDs) over the next 20 years could reach $47 trillion, more than three times the current national debt.

Also, the World Health Organization (WHO) said on Sunday that poorer countries could introduce measures to prevent and treat millions of cases of cancer, diabetes, heart disease, mental illness and respiratory disease for as little as $1.20 per person per year.

These topics are at the forefront of a landmark two-day health summit starting the UN General Assembly week in New York. The summit is expected to launch a discordant debate on the cost and responsibility for the five leading chronic diseases that kill more than 36 million people a year combined.

Non-communicable diseases account for more than 63 percent of all deaths worldwide, with about 80 percent of these deaths occurring in developing countries such as those in Africa, Asia and the Middle East.

The WEF study noted that the estimated cumulative outpost loss caused by these illnesses represents about 4 percent of annual global gross domestic product (GDP) over the coming two decades.

“This is not a health issue, this is an economic issue — it touches on all sectors of society,” Eva Jane-Llopis, WEF´s head of chronic disease and wellness, told Reuters in a telephone interview.

The WHO predicts by 2030, the global NCD epidemic will accelerate to more than 52 million deaths per year.

NCDs are often thought of as diseases of wealthy countries, where fatty foods, idle lifestyles and heavy use of tobacco and alcohol have become a mainstay for many people. But the risk of these diseases have become more prevalent in poorer countries in the past two decades, especially where access is limited to medicines and doctors, and knowledge on preventative measures is patchy at best.

WEF´s research, conducted with Harvard School of Public Health, and published on Sunday, found that the cost of NCDs in developing countries is expected to top $7 trillion by 2025. Mental illness alone will account for nearly $16 trillion in medical costs worldwide, more than a third of the overall estimate for all NCDs.

The study shows how families, countries and economies are losing people in their most productive years, said Olivier Raynaud, the WEF´s senior director of health.

“Until now, we´ve been unable to put a figure on what the World Health Organization calls the ℠world’s biggest killers´” he said in a statement. But the numbers suggest NCDs “have the potential to not only bankrupt health systems but to also put a brake on the global economy,” he added.

To tackle the NCD epidemic head on, the WHO made a list of recommendations that include measures that target whole populations, such as excise taxes on tobacco and alcohol, legislating for smoke-free indoor workplaces and public places, campaigns to reduce levels of salt and trans fats in foods, and the creation of public awareness programs to help people improve their eating habits and increase their physical activity.

Other measure include screening, counseling and medications for people who are at risk of heart disease, screening for cervical cancer, and immunization against hepatitis B to prevent liver cancer.

The two-day meeting is the only second-ever high-level meeting to be held on a global health threat — the first was ten years ago on HIV/AIDS.

But health organizations and delegates worry that big consumer firms that sell processed foods, alcohol and tobacco might takeover the meeting and persuade governments away from setting targets and making commitments against such industries.

The summit’s summarized final statement takes tentative steps toward laying the blame for the deaths.

The UN member states “recognize that the most prominent NCDs are linked to common risk factors, namely tobacco use, harmful use of alcohol, and unhealthy diet, and lack of physical activity.” They concur that NCDs are “one of the major challenges for development in the 21st century.”

“Poor populations and those living in vulnerable situations, in particular in developing countries bear a disproportionate burden,” the statement said.

NCDs are now at “epidemic level” and are a challenge to be confronted by all countries, said Anne Keeling, president of the NCD Alliance, which is the core of about 2,000 health organizations worldwide.

Keeling, who is also CEO of the International Diabetes Federation, said there are currently around 344 million people around the world suffering from diabetes and that number will soon surpass 500 million.

The summit´s statement says prevention must be the foundation of worldwide efforts to take control of chronic disease. But many experts are urging leaders to take an even tougher stance.

“Voluntary guidelines are not enough. World leaders must not bow to industry pressure,” said Olivier De Schutter, the UN℠s Special Rapporteur on the Right to Food. “It is crucial for world leaders to counter food industry efforts to sell unbalanced processed products and ready-to-serve meals too rich in transfats and saturated fats, salt and sugars.”

Aid for poorer countries will also be an issue at the summit. Aid in such countries currently makes up less than 3 percent of official development aid, much less than the aid given to tackle transmissible diseases like malaria, said Ala Alwan, deputy director general of the WHO.

“The need for immediate action is critical to the future of the global economy.” WEF’s executive chairman Klaus Schwab said.

The WEF study used three modeling methods to calculate the costs of NCDs — the WHO’s EPIC model, the Value of Statistical Life (VSL) approach and the Cost-Of-Illness (COI) approach.

On the Net:

Nanoparticles Cause Brain Injury In Fish

Scientists at the University of Plymouth have shown, for the first time in an animal, that nanoparticles have a detrimental effect on the brain and other parts of the central nervous system.
They subjected rainbow trout to titanium oxide nanoparticles which are widely used as a whitening agent in many products including paints, some personal care products, and with applications being considered for the food industry. They found that the particles caused vacuoles (holes) to form in parts of the brain and for nerve cells in the brain to die. Although some effects of nanoparticles have been shown previously in cell cultures and other in vitro systems this is the first time it has been confirmed in a live vertebrate.
The results will be presented at the “6th International meeting on the Environmental Effects on Nanoparticles and Nanomaterials” (21st — 23rd September) at the Royal Society in London.
“It is not certain at this stage of the research whether these effects are caused by the nanoparticles entering the brain or whether it is a secondary effect of nanoparticle chemistry or reactivity”, says Professor Richard Handy, lead scientist.
The results of Professor Handy’s work and that of other researchers investigating the biological effects of nanoparticles may influence policy regulations on the environmental protection and human safety of nanomaterials.
“It is worrying that the effects on the fish brain caused by these nanoparticles have some parallels with other substances like mercury poisoning, and one concern is that the materials may bioaccumulate and present a progressive or persistent hazard to wildlife and to humans”, says Professor Handy.

On the Net:

Yogurt Consumption While Pregnant Could Lead to Childhood Asthma

 

Eating low-fat yogurt during pregnancy could increase the risk that an unborn child will develop asthma and/or hay fever, researchers from the U.S. and Denmark claim in a new study.

Experts at the Harvard School of Public Health and the Center for Fetal Programming at Statens Serum Institut discovered that women who consumed the low-fat dairy product were 1.6 times more likely to have children who develop asthma by the age of seven.

They had reportedly sought to determine whether or not milk and dairy intake while pregnant could help prevent the development of allergies of children. They determined that drinking milk not only did not increase asthma risk, but actually helped to prevent it.

“This is the first study of its kind to link low-fat yogurt intake during pregnancy with an increased risk of asthma and hay fever in children,” lead author Ekaterina Maslova of Harvard said in a statement.

“This could be due to a number of reasons and we will further investigate whether this is linked to certain nutrients or whether people who ate yoghurt regularly had similar lifestyle and dietary patterns which could explain the increased risk of asthma,” she added.

In an interview with BBC News, she called it “a puzzling finding.”

“The absence of fatty acids in low-fat yogurt may be key to the results,” Maslova said. “The results suggest that fatty acids play an important role or it could be that people who ate this kind of yoghurt had similar lifestyle and dietary patterns, but we cannot make any conclusions at this stage“¦ We need to replicate these results in other studies first.”

The entire study will be presented at the European Respiratory Society’s (ERS) Annual Congress in Amsterdam on September 25, the ERS said in a September 17 press release. According to AOL News UK, a total of 61,912 women participated in the study.

On the Net:

CDC: Drug Deaths Outnumber Traffic Fatalities

 
Drug-related deaths outnumbered motor vehicle related fatalities in 2009, according to reports published Sunday by the Associated Press (AP) and the Los Angeles Times.
The AP, citing “preliminary” Centers for Disease Control and Prevention (CDC) statistics, shows that there were 37,485 drug-related fatalities that year.
The Times noted that there were 36,284 traffic-related deaths in 2009, and that drug-induced deaths had also surpassed motor vehicle related ones in 23 states and Washington D.C.
“While most major causes of preventable death are declining, drugs are an exception,” Lisa Girion, Scott Glover and Doug Smith reported on Saturday. “The death toll has doubled in the last decade, now claiming a life every 14 minutes. By contrast, traffic accidents have been dropping for decades because of huge investments in auto safety.”
“Public health experts have used the comparison to draw attention to the nation’s growing prescription drug problem, which they characterize as an epidemic,” they added. “This is the first time that drugs have accounted for more fatalities than traffic accidents since the government started tracking drug-induced deaths in 1979.”
The reason for the increase, according to the trio of Times reporters, is the abuse of increasingly potent and addictive prescription pain and anxiety medication, especially when used in combination with other substances.
Among the most commonly abused drugs are OxyContin, Vicodin, Xanax and Soma, say Girion, Glover, and Smith.
“Such drugs now cause more deaths than heroin and cocaine combined,” they claim.
According to the Daily Mail, the CDC statistics researched by the Times showed that deaths tied to drugs such as OxyContin, Valium and Xanax had doubled over a 10 year span. Meanwhile, car deaths had fallen, most likely due to “interest and investments into car safety.”
The study came on the heels of a new study, published recently in The Journal of Pediatrics, which found that the number of children needing emergency medical attention following accidental prescription drug overdose was on the rise.
From 2001 to 2008, doctors at the Cincinnati Children’s Hospital Medical Center observed a 30% increase in such cases, mostly due to the youngsters themselves gaining access to prescription painkillers, diabetes medication, and pills designed to lower blood pressure.
University of Western Ontario pediatrician and pharmacology researcher Dr. Michael Rieder told the UK newspaper that the results of the study were “a bit alarming“¦ I think people have been under the assumption that the rate of poisoning [in children] is fairly stable. Our assumption is wrong.”
“The big thing to take away from this is we need to do a better job of keeping children and medicines away from each other in the home,” added Dr. Eric Lavonas, from the Rocky Mountain Poison and Drug Center in Denver. Neither Rieder nor Lavonas participated in the Cincinnati study.

On the Net:

Scientists Concerned By Continued Eruptions At Alaskan Volcano

 

The two-month long, low-level eruptions occurring at a volcano in Alaska’s Aleutian Islands have volcanologists worried that there could be a larger eruption forthcoming, Yereth Rosen of Reuters reported on Friday.

The volcano causing concern is Cleveland Volcano (also known as Mount Cleveland), a 5,676-foot peak located less about 940 miles southwest of Anchorage.

As previously reported here on RedOrbit, an eruption warning was issued by the Alaska Volcano Observatory in late July.

At that time, the Daily Mail warned that Cleveland Volcano “could be poised for its first big eruption in ten years,” and that experts believed that it could “erupt at any moment, spewing ash clouds up to 20,000 feet above sea level with little further warning.”

Nearly eight weeks later, such an eruption remains a definite possibility.

“The big thing we’re concerned about is an explosive eruption,” Steve McNutt of the University of Alaska Fairbanks, a coordinating scientist for the observatory, told Rosen.

Such an eruption, the Reuters reporter says, could come with “little warning.” Satellite imagery has reportedly shown a lava dome growing inside the volcano’s crater, and the observatory has reports that Mount Cleveland continues to generate heat. To date, there have been no signs of ash clouds, Rosen said, but those, too, could come with little warning.

McNutt told Reuters that they are concerned that the dome could completely seal off the crater vent, thus causing pressure to build until it is released suddenly and violently. Alternatively, the dome could topple, which would trigger “molten flow down the mountain that releases gas and ash into the atmosphere while lava and rocks tumble,” Rosen said.

Cleveland Volcano rests underneath a flight path between North America and Asia that is said to be utilized by several major airlines, which means that an eruption there could create havoc when it comes to airline travel.

Twenty-one confirmed eruptions have taken place at Cleveland Volcano over the past 230 years, with the only fatality coming in 1944, when a US soldier stationed there during World War II went missing and was presumed dead following a VEI 3 level eruption. The mountain erupted twice in 2010 and three times in 2009.

As of 11:53 a.m. Saturday, the Aviation Color Code at the volcano was Orange, with the following notice posted on the Observatory website: “No activity observed in mostly cloudy satellite images from the past day. No ash emissions have been observed during this current eruptive episode that began in mid-July 2011. No other new reports have been received regarding the volcano.”

“The current episode of dome growth resumed around September 3,” the Observatory status report added. “A growing lava dome in the crater increases the possibility of an explosive eruption, but does not necessarily indicate that one will occur. Short-lived explosions could produce ash clouds that exceed 20,000 ft above sea level. These events can occur without warning and may go undetected in satellite imagery for hours. If lava dome growth continues, it could overflow the crater rim to produce a lava flow and/or collapse to produce pyroclastic flows. Collapse of a lava flow or dome would likely result in the generation of a volcanic ash cloud.”

Image Caption: This GeoEye IKONOS image shows a faint plume issuing from Cleveland Volcano at 2:31 PM on September 14, 2010. Red in this image highlights areas of vegetation detected by the near-infrared channel. Credit/Copyright: 2010 – GeoEye

On the Net:

The Pain-o-meter: Seeing Pain

(Ivanhoe Newswire) — More than 100 million Americans suffer chronic pain. Detecting this pain relies heavily on self-reporting, which can be confusing or ill-communicated. Now, researchers from the Stanford University School of Medicine have taken a first step toward developing a diagnostic tool that could eliminate this major hurdle in pain medicine.
“People have been looking for a pain detector for a very long time,” Sean Mackey, MD, PhD, chief of the Division of Pain Management, and associate professor of anesthesiology was quoted as saying.
“We rely on patient self-reporting for pain, and that remains the gold standard,” Dr. Mackey adds, “But there are a large number of patients, particularly among the very young and the very old, who can’t communicate their pain levels. Wouldn’t it be great if we had a technique that could measure pain physiologically?”
The subjective nature of pain has made this an elusive goal. However, advances in neuroimaging techniques have re-invigorated the debate over whether it might be possible to measure pain physiologically.
According to a study that will be published in the online journal PLoS ONE, the new tool would use patterns of brain activity to give an objective physiologic assessment of whether someone is in pain. The scientists used functional magnetic resonance imaging (MRI) scans of the brain combined with advanced computer algorithms to accurately predict thermal pain in healthy subjects.
“We’re hopeful we can eventually use this technology for better detection and better treatment of chronic pain,” Dr. Mackey was quoted as saying.
The idea for the study was born at a 2009 Stanford Law School event organized by Stanford Law professor Hank Greely, which Dr. Mackey attended. The event brought together neuroscientists and legal scholars to discuss how the neuroimaging of pain could be used and abused in the legal system.
“At the end of the symposium, there was discussion about the challenges of creating a ‘painometer’,” Dr. Mackey was quoted as saying.
$600 billion in medical expenses are accrued every year by chronic pain patients, according to a study released by the Institute of Medicine. The study also found cultural biases against pain sufferers, portraying them as liars about their pain.
According to Greely this not only complicates the delivery of appropriate treatment, but also creates hundreds of thousands of legal cases each year that hinge on the existence of pain.
“A robust, accurate way to determine whether someone is in pain or not would be a godsend for the legal system,” Greely was quoted as saying.
Two young scientists were up to the challenge, Neil Chatterjee, MD/PhD student at Northwestern University, and Justin Brown PhD and first author of the study.
They put eight subjects in the brain-scanning machine; and applied a heat probe to their forearms causing moderate pain. The brain patterns were then recorded and interpreted by the computer to create a model of what pain looks like.
The computer was then asked to consider the brain scans of eight new subjects and determine whether they had thermal pain. The computer did amazingly well, successfully detecting what pain looks like 81 percent of the time.
“I was definitely surprised,” Chatterjee was quoted as saying.
Researchers stressed that future studies are needed to determine whether these methods will work to measure various kinds of pain, and whether they can distinguish between pain and other emotionally arousing states such as anxiety or depression.
SOURCE: PLoS ONE, published online September 13, 2011

Despite Over 20,000 Deaths Daily, Child Mortality Rate Is Falling

  

UNICEF and the World Health Organization (WHO) released a study this week showing the mortality rate of children under the age of five years old has fallen to 7.6 million global deaths in 2010 from more than 12 million in 1990, Reuters is reporting.

Dr. Margaret Chan, director general of the WHO explains, “This is proof that investing in children´s health is money well spent, and a sign that we need to accelerate that investment through the coming years.”

Chan continues by saying many factors contribute to reductions in child mortality, including better healthcare for newborns, prevention and treatment of childhood diseases, clean water and better nutrition, are just some of the reasons for the reductions in child mortality during this time frame.

Even in portions of the globe that have traditionally been hardest on children, such as sub-Saharan Africa, the rate of improvement has more than doubled, although the number of children who die from preventable causes is still more than 21,000 per day worldwide.

Anthony Lake, executive director of the United Nations Children´s Fund or UNICEF explains, “Focusing greater investment on the most disadvantaged communities will help us save more children´s lives, more quickly and more cost effectively.”

Five countries, India, China, Pakistan, Nigeria and Democratic Republic of Congo account for half of all deaths among children under five years of age with babies being particularly vulnerable, BBC News reports. According to the report, more than 40 percent of deaths in children under the age of five occur within the first month of life and more than 70 percent in the first year of life.

Ian Pett, chief of Health Systems and Strategic Planning at UNICEF, said in a telephone interview with Julie Steenhuysen of Reuters, “There is more attention being paid to what ensures health globally.” For example, he said the government of Sierra Leone in April lifted all fees for child and maternal health, prompting a big improvement in child mortality rates.

“Many other countries are trying to do the same thing,” Pett explained.

Countries in Sub-Saharan Africa and Southern Asia give high priority to reducing child mortality, particularly by targeting the major killers of children (including pneumonia, diarrhea, malaria and under nutrition) with effective preventative and curative interventions.

Sierra Leone in West Africa, one of the world´s poorest nations, ranks among the top five countries seeing improvements in child mortality in the past decade. The others were Niger, Malawi and Liberia – also in Africa — and East Timor in South East Asia.

On the Net:

Darden Restaurants Joins Michelle Obama To Improve Menus

 
Darden Restaurants, one of the largest operators of restaurants in the US that includes Olive Garden, Red Lobster, Capital Grille and Seasons 52, pledged Thursday to assist First Lady Michelle Obama´s “Let´s Move!” campaign in helping to fight childhood obesity with healthier menu options for children.
The First Lady and the Partnership for a Healthier America joined company leaders at an Olive Garden in Hyattsville, MD to announce its commitment, according to a Darden Restaurant press release.
Drew Madsen, President and Chief Operating Officer of Darden Restaurants said, “As a leader in culinary innovation, we pride ourselves on making good food better, and on finding new ways to nourish and delight everyone we serve Today we are taking a new step forward by creating a comprehensive health and wellness commitment, while preserving our commitment to offer our guests the delicious food they have come to know and love from their favorite Darden restaurants.”
Darden´s effort is a threefold commitment that includes a promise to reduce its overall calorie footprint, which will reduce calories by 10 percent over five years and a 20 percent decrease of calories over 10 years. The calories will be reduced by the company looking at reformulating, resizing and removing items from the menu and introducing new calorie-conscious, flavorful choices.
The second commitment is to reduce the sodium content by 10 percent over the next five years and 20 percent over the next 10 years. Darden will work with its suppliers to transition its menu items to align with national nutrition policy and allow for the evolution of consumer taste preferences and market innovations.
Moreover they will commit to healthier menu choices for the children´s menu that will appeal to kids and parents. They promise to make fruits or vegetables the default side dishes and an 8 ounce serving of 1 percent milk is the default drink option with free refills.
According to the White House press release, First Lady Michelle Obama welcomed the occasion by saying, “Darden is working to make the healthy choice the easy choice, and they´re making it the delicious and fun choice too. I´m confident that if companies like Darden continue to be creative and innovative and keep our kids´ best interests at heart then we will solve the challenge of childhood obesity and give all our kids the healthy futures they deserve.”

Image Caption: First Lady Michelle Obama and a Darden Restaurants chef greet attendees at an Olive Garden restaurant in Hyattsville, Maryland, Sept. 15, 2011. Mrs. Obama and Darden Restaurants were unveiling the company’s plans for a comprehensive new health and wellness initiative for menu changes to support the Let’s Move! campaign. (Official White House Photo by Chuck Kennedy)

On the Net:

Notre Dame Researchers Demonstrate Antibiotic Sensing Event Central To MRSA Antibiotic Resistance

A new paper by a team of University of Notre Dame researchers that included Shahriar Mobashery, Jeffrey Peng, Brian Baker and their researchers Oleg Borbulevych, Malika Kumararasiri, Brian Wilson, Leticia Llarrull, Mijoon Lee, Dusan Hesek and Qicun Shi describes a unique process that is central to induction of antibiotic resistance in the problematic bacterium methicillin-resistant Staphylococcus aureus (MRRA).
MRSA first emerged in the United Kingdom in 1961and spread rapidly across the globe. Modern strains of MRSA are broadly resistant to antibiotics of various classes, but resistance to B-lactam antibiotics, which include penicillins, cephalosporins, and carpapenems, is an acute problem because it impacts virtually all commercially available members of the class.
Earlier research by Mobashery, who holds the Navari Family Chair of Life Sciences at Notre Dame, found that an antibiotic sensor/signal transducer protein called “BlaR1” is a key player in MRSA’s resistance to β-lactam antibiotics. Specifically, he had detected by spectroscopy a unique recognition process by the BlaR1 protein of the antibiotic that the organism might encounter. This recognition event, termed “Lysine N-Decarboxylation Switch,” involved formation of an N-carboxylated lysine within the antibiotic-binding domain of BlaR1, which experiences decarboxylation on binding to the antibiotic. This decarboxylation gives the antibiotic complex longevity, which benefits MRSA in the face of the antibiotic challenge. Although this antibiotic-recognition event was described by Mobashery’s research group a few years earlier, the process was not visualized in atomic resolution, despite attempts by several other research groups.
The three collaborating groups of Notre Dame researchers approached the problem differently. The Peng group studies the process by three- and two-dimensional NMR spectroscopy in Notre Dame’s Lizzardo Magnetic Resonance Research Center, the Baker group grew new crystals of the protein for x-ray diffraction and the Mobashery group applied computational methods to understand the process.
The efforts paid off, as Peng demonstrated the presence of N-carboxylated lysine in the protein and showed that it undergoes N-decarboxylation on binding to the antibiotic in solution. Baker visualized both the N-carboxylated lysine in the x-ray crystal structure of the uncomplexed form and showed that when the antibiotic complexed with the protein, the N-decarboxylation switch resulted in a stable complex critical to the manifestation of resistance.
The lysine N-decarboxylation switch triggers MRSA’s antibiotic sensor domain to adopt the active state that leads to all the subsequent biochemical processes that enable resistance, an event that was investigated by computational analyses in the Mobashery lab in the present study.
The importance of this lysine N-decarboxylation switch for MRSA rests in the fact that the organism does not mobilize its resources until and unless it is exposed to the antibiotic. As such, in an economy of existence, the MRSA conserves its resources until BlaR1 informs it that it has come in contact with a B-lactam antibiotic.
The research paper describing the team’s findings appears in the Journal of Biological Chemistry.

On the Net:

Excessive Body Odor May Be Caused By Genetic Disorder

 

Researchers from Monell Chemical Senses Center in Philadelphia are reporting that people with unexplained body odor issues may be suffering from a metabolic disorder, trimethylaminuria (TMAU) or “fish-odor syndrome”.

TMAU is a genetically-transmitted disease that inhibits the ability of an enzyme to metabolize or transform trimethylamine (TMA) and is not based on lack of hygiene or personal care. Instead, the condition becomes apparent when sufferers digest foods rich in a substance called choline which include saltwater fish, eggs, liver and certain legumes, such as soy and kidney beans, Reuters is reporting.

Giving these people a definitive diagnosis offers relief to these individuals, as symptoms of TMAU can cause social and interpersonal stress. The debilitating symptoms can be lessened primarily with an altering of the diet.

“Health care professionals must arrive at a correct diagnosis to suggest appropriate treatment,” said study lead author Paul M. Wise, Ph.D., a sensory psychologist at Monell. “This research raises awareness of both the disease and also the proper methods of diagnosis and treatment.”

The American Journal of Medicine released the study online and included the testing of 353 patients who had contacted the Monell Center because of unexplained personal odor issues. Underlying causes could not be identified by medical and dental professionals.

Subjects of the study engaged in a choline challenge, in which each patient ingests a set amount of choline, with urinary TMA levels measured over the next 24 hours. A high level of urinary TMA confirmed a diagnosis of TMAU in 118 individuals.

George Preti, Ph.D., an analytical organic chemist at Monell explains, “Although the scientific and popular literature typically describes TMAU sufferers as smelling fishy, our sensory exams demonstrated this not to be so. The odors are diverse and only after a choline challenge do the most severe cases have a fish-like odor.”

Classified as a “rare disease,” meaning that it affects less than 200,000 people in the United States, actual incidence of TMAU remains questionable, due in part to the previously incomplete diagnostic techniques. Discerning the genetic and dietary bases of these differences in the condition will be the subject of future research.

An actual sufferer of the condition must inherit a defective copy of the FMO3 gene from both parents, who themselves would be unaffected “carriers.” If either of the parents had the disorder they would pass it on to their children.

On the Net:

Dark Chocolate ‘As Good As Exercise’

 
Scientists from Wayne State University have discovered that a compound found in chocolate, called epicatechin, seems to trigger the same muscle response as vigorous activity such as jogging.
Additionally, when small doses of chocolate are consumed in combination with regular exercise, performance is increased by 50 percent, the study found.
The researchers found that epicatechin seemed to increase the number of mitochondria, tiny powerhouses in cells that generate energy.
“Mitochondria produce energy which is used by the cells in the body. More mitochondria mean more energy is produced the more work can be performed,” study leader Dr. Moh Malek at Wayne State University in Detroit, Michigan, told the UK telegraph.
“Aerobic exercise, such as running or cycling, is known to increase the number of mitochondria in muscle cells. Our study has found that epicatechin seems to bring about the same response – particularly in the heart and skeletal muscles,” he added.
The researchers conducted their study on three groups of middle-aged mice.  One group was fed a type of epicatechin from cocoa twice a day for 15 days, while another group had epicatechin and also underwent 30 minutes of treadmill training every day.   A third group did the exercise but without consuming the epicatechin.
The researchers found that the group of mice that were only fed epicatechin had the same exercise performance as those running on the treadmill without consuming epicatechin.  However, the mice that both exercised and consumed epicatechin showed an even greater benefit.
The scientists said they hope the study will lead to better ways of fighting age-related muscle wasting.
“The number of mitochondria decreases in skeletal muscle as we age, and this affects us physically in terms of both muscle energy production and endurance,” said Dr. Malek.
“Applying what we know about epicatechin’s ability to boost mitochondria numbers may provide an approach to reduce the effects of muscle ageing.”
“It appears epicatechin treatment combined with exercised could be a viable means to offset muscle ageing,” said Dr. Malek.
“At the moment it would be a leap of faith to say the same effects would be seen in humans. But it is something we hope to identify in future studies.”
The study is published September 14 in the Journal of Physiology.

On the Net:

Investigating The Spread Of Infectious Diseases

How diseases are transmitted among humans, other animals, the environment is focus
New research aimed at controlling the transmission of diseases among humans, other animals and the environment is being made possible by grants from a collaboration among U.S. and U.K. funding agencies.
By improving our understanding of the factors affecting disease transmission, the projects will help produce models to predict and control outbreaks.
Funding is from the U.S. National Science Foundation (NSF) and U.S. National Institutes of Health (NIH) Ecology and Evolution of Infectious Disease (EEID) Program.
It is also being provided by the U.K. Ecology of Infectious Diseases Initiative of the Biotechnology and Biological Sciences Research Council (BBSRC), and U.K. Economic and Social Research Council (ESRC).
Combined, the grants total $17 million.
Research supported by the U.S.-U.K. collaboration aims to combat diseases that are particularly prevalent and damaging in the developing world, especially those transmitted from animals to humans, called zoonoses.
About 75 percent of recently emerging diseases are infections that may be transmitted between animals and humans. They pose serious threats to human health and to global food security.
Projects will draw on expertise from both the biological and social sciences to help public health workers in the developing world combat the emergence and spread of disease.
For example, scientists will conduct research on the transmission of bacterial diseases that cause fever in Tanzania, with the hope of developing better control strategies.
Another project will investigate the spread of a viral disease related to HIV in colobus monkeys. The researchers hope to gain insights into how HIV was initially transmitted from animals to humans.
Other projects aim to further an understanding of how viruses evolve to infect their hosts.
Researchers in the U.S. will also investigate white-nose syndrome in eastern bats, sudden oak death in western trees and parasitic diseases in west coast estuaries.
“The research funded through this program stretches from an understanding of host-pathogen co-evolution, to better management of California forests threatened by disease, to knowledge of viral transmission in African monkeys that will provide answers about the emergence of HIV/AIDS,” says Sam Scheiner, NSF program director for EEID. Funding for NSF’s contribution to the program primarily comes from its Directorates for Biological Sciences and Geosciences, as well as its Directorate for Social, Behavioral & Economic Sciences.
Researchers hope to gain insights into why some viruses infect a number of different organisms, whereas others are specialized to infect just one.
“A multidisciplinary approach to understanding disease transmission dynamics is critical for the prediction, prevention and control of emerging and reemerging disease threats,” says Christine Jessup, EEID program director at NIH’s Fogarty International Center. “This year’s projects address how human and natural processes influence infectious disease dynamics that are of global health concern, while building capacity for global health research.”
“Infectious diseases pose a worldwide threat to the health of both humans and livestock that requires an international solution, ” says Douglas Kell, Chief Executive of BBSRC. “By coordinating the expertise of a diverse range of scientists in the U.K. and U.S., these projects will help farmers and officials in the developing world manage this threat.”
“Addressing the social and economic implications of infectious diseases, along with their biological implications, is essential to developing a comprehensive understanding of this key global challenge,” says Paul Boyle, chief executive of the ESRC.
“This trans-Atlantic initiative creates an opportunity for the best U.K. social scientists to collaborate with the best researchers from the U.S., and for them to develop strategies to help health professionals and policy-makers within and beyond the U.K. to combat existing and emerging diseases.”
NSF-NIH ECOLOGY AND EVOLUTION OF INFECTIOUS DISEASE (EEID) AWARDS – 2011

Title: Biological and human dimensions of primate retroviral transmission

PI: Tony Goldberg, University of Wisconsin – Madison
Summary: To better understand how HIV spread from its origin in monkey populations to humans, researchers will study similar viruses currently circulating among wild monkeys in Uganda. By combining data from both the biological and social sciences, this project will focus on the transmission within and between wild animal species and what human social factors–such as awareness, beliefs and behaviors–increase the likelihood of transmission from animals to people.
Title: The effect of sociality on transmission and spread of a multi-host pathogen
PI: Thomas Kunz, Boston University
Summary: The recent emergence of a fungal disease known as white-nose syndrome has devastated hibernating bat populations across eastern North America. This research will investigate how social behavior among bats (such as group size and mixing patterns) influences the spread of the fungal pathogen at local, regional and continental scales.
Title: Impact, ecology and social determinants of bacterial zoonoses in northern Tanzania
PI: John Crump, Duke University
Summary: This project will examine the environmental and social factors that set the stage for the transmission of bacterial diseases from livestock to humans. Scientists will focus on three distinct livestock-owning communities in Tanzania to quantify transmission rates and examine the impact of potential control strategies. They will investigate the factors that affect the transmission of bacterial diseases that cause fever in Tanzania, including those that relate to Leptospirosis (Weil’s disease) to develop better control strategies.

Title: Interacting disturbances: leaf to landscape dynamics of emerging disease, fire and drought in California coastal forests

PI: David Rizzo, University of California – Davis
Summary: This research aims to better understand how the interaction of multiple factors like wildfire, drought, biodiversity and nutrient cycles can interact to regulate disease dynamics. Using long-term studies of sudden oak death, estimated to have killed millions of trees in the western U.S., scientists hope to gain new insights about how the emergence, persistence and spread of a pathogen is controlled by environmental disturbance.
Title: Transmission and coevolutionary dynamics drive the evolution of generalist and specialist viruses
PI: Samantha Forde, University of California – Santa Cruz
Summary: This project will use a simplified laboratory system of E. coli bacteria and its viruses as a model to study why some viruses have evolved the ability to infect multiple host species, while others can only infect one. By combining experiments at all levels of virus and host interaction–from genes to cells to populations–with a mathematical modeling framework, this work will further a general understanding of the dynamics of disease in natural systems and help to improve public health initiatives.
Title: Modeling the effects of heterogeneity in water quality on cholera disease dynamics
PI: Joseph Tien, Ohio State University
Summary: Deadly outbreaks of cholera among people in Haiti, Angola and elsewhere can broadly be blamed on poor water quality. However, more knowledge is needed about how the spread of disease relates to the distribution and variation of water quality and treatment facilities across different types of communities (such as shanty-towns, tent camps and commercial centers). This study will use mathematical models and in-depth analyses of outbreaks to investigate how these differences affect the ability of cholera and other waterborne diseases to invade, spread, and remain in a population.
Title: Disease at the margins of species ranges: anther-smut on alpine species.
PI: Janis Antonovics, University of Virginia
Summary: This project will address questions about how the spatial distribution of a species is influenced by disease.  Researchers will conduct experiments on alpine plant populations to determine the role of a fungus in regulating the spread of its host plant species, as well as whether host individuals at the edge of their species’ ranges are more likely to contribute to cross-species disease transmission.
Title: Modeling infectious diseases: how much ecological complexity must we address?
PI: Armand Kuris, University of California – Santa Barbara
Summary: In nature, a parasitic species inhabits a complex world of interactions among alternative hosts, competitors for resources, and the environment. However, mathematical models used to study infectious disease dynamics typically reduce this system to a simple depiction of only a single pathogen in a single host population. To test how much influence the ecological complexity of a system has on disease dynamics, scientists will study parasitic diseases in several estuaries along the coast of California and Baja California and will model parasite dynamics in food webs of different complexity, under different temperatures, and for parasites with complex life cycles.

Image Caption: EEID scientists work to answer questions like how HIV spread from monkeys to humans. (Credit: Tony Goldberg, University of Wisconsin-Madison)

On the Net:

Web Tool Aims To Improve The Workplace For Breast Cancer Survivors

In a paper to be presented at the upcoming HFES 55th Annual Meeting in Las Vegas, Nevada, human factors/ergonomics researchers will describe WISE, a Web-based tool for breast cancer survivors designed to reduce work disabilities and improve employment outcomes.
 
Those who have beaten breast cancer comprise the largest population of cancer survivors in the United States. Many return to the workplace after treatment, but symptoms and long-term side effects can impact their ability to do their work. However, the good news is that very simple strategies can address these issues.

In the presentation “Improving Employment Outcomes of Breast Cancer Survivors: Development of a Web-Based Educational and Decision Support Tool,” authors Mary Sesto, Rebecca Wachowiak, Amye Tevaarwerk, Mahpara Faatin, Susan Heidrich, and Douglas Wiegmann explain how the WISE (Work ability Improvement through Symptom management and Ergonomic education) system can help survivors manage their symptoms, identify ergonomic workplace problems and risks, and implement workplace changes.

WISE users answer general screening questions about work-related activities and complete a checklist of specific work tasks, problems, and current symptoms (e.g., fatigue, pain). WISE provides users with tailored information on ergonomic changes they can make to increase their comfort in the workplace, along with tips for alleviating their symptoms.

“No effective intervention exists to improve employment outcomes following any cancer diagnosis, including breast cancer,” says Sesto. “There was a need to develop an interdisciplinary resource that provides customized information and decision support tools on how to effectively manage some of the problems that people may encounter in the workplace during and following cancer treatment. In our preliminary testing, both employers and survivors found the information in WISE to be helpful.”

Sesto and colleagues hope that WISE will help not only survivors who have returned to the workplace but also the roughly 30% of previously employed cancer survivors who have not returned to work. If WISE proves to be a successful and viable tool, Sesto and her team will develop additional tools that can be used by survivors of other types of cancer.

For more information on this and other research being presented at the HFES Annual Meeting, contact HFES Communications Director Lois Smith ([email protected], 310/384-1811). 

On the Net:

Primary Schoolchildren That Sleep Less Than 9 Hours Do Not Perform

A study by the Autonomous University of Barcelona (UAB in Spanish) and Ramón Llull University have researched the relationship between the sleeping habits, hours slept, and academic performance of children aged between six and seven years of age. Experts have found that sleeping less than nine hours, going to bed late and no bedtime routine generally affects children’s academic skills.

“Most children sleep less than is recommended for their intellectual development, which is hindered because the lack of sleep cannot be recovered. This is the first Spanish study that proves that losing out on hours of sleep and bad habits affect schoolchildren’s academic performance,” stated Ramón Cladellas, researcher at the Faculty of Psychology at the UAB.

The study’s authors, published in the journal Cultura y Educación, assessed a total of 142 primary schoolchildren (65 girls and 77 boys) from different schools and which did not have any sleep-related pathological changes. Parents were asked to fill out a questionnaire, concerning the children’s habits and number of hours slept per night. The experts also assessed a series of academic skills: communicative, methodological, transversal and specific.

“Although the sample of children sleep almost 8 hours, their sleeping habit shows us that 69% return home after 9pm at least three evenings a week or they go to bed after 11pm at least four nights a week. As such, pupils that sleep 8 or 9 hours have a worse performance than those that sleep 9 or 11 hours,” the experts pointed out.

“Taking into account the results obtained, we believe that more than 9 hours sleep and a nightly routine favors academic performance,” added Cladellas.

Losing out on hours of sleep and bad habits produced negative effects, especially on more generic skills (communicative, methodological and transversal) which are essential for academic performance. However, there is a lesser effect on the specific skills, more related to cognitive aspects, such as memory, learning and motivation, and they are seen to be more altered by irregular sleep patterns.

“To this end, the lacking hours of sleep distorts children’s performance in linguistic knowledge, grammar and spelling rules, and key aspects in the organization and comprehension of texts, to name a few examples. They are basic skills, meaning that if the pupil, due to a lack of sleep, develops problems in this area, it could have a repercussion on all subjects,” explained Cladellas.

The authors concluded that maintaining a healthy sleep pattern at this age contributes to positive cognitive development. They suggest that parents attend prevention programs to become more aware of the matter.

“Nowadays, there is great concern because children are glued to the television, computers, and videogames, but the same importance is not given to them going to bed at the same time every night,” concluded Cladellas.

On the Net:

USDA Banning 6 Types Of E. Coli From Ground Beef

 
According to multiple media reports, the U.S. Department of Agriculture (USDA) is planning to add six types of E. coli bacteria to its list of adulterants that are banned from being sold in raw beef.

The USDA said it will be focusing on six other strains of E. coli that have been found in food in recent years and have made people sick the same way the O157:H7 strain can.

A report by the Wall Street Journal said the new USDA plan was set to take effect in March 2012 after a public comment period. 

The American Meat Institute’s James Hodges said that instead of making these E. coli’s illegal, the USDA should have spent the money focusing on “preventive strategies.”

“Imposing this new regulatory program on ground beef will cost tens of millions of federal and industry dollars — cost that will likely be borne by taxpayers and consumers,” AMI said in a statement.

The E. coli O104:H4 recently caused thousands to become ill in Germany recently.  However, this strain is absent from the USDA’s list, according to a USA Today report.

“This is a big win for consumers. In the wake of many recent food recalls caused by E. coli contamination, it is critical that we take the necessary steps to protect the health and well being of all consumers,” Ami Gadhia, senior policy counsel for Consumers Union, told USA Today.

Some companies, like Costco, are already requiring suppliers to test for these strains.

On the Net:

World Alzheimer’s Report 2011: The Benefits Of Early Diagnosis And Intervention

Early diagnosis of Alzheimer’s disease has health, financial and social benefits: Call for nations to support early diagnosis and intervention

The World Alzheimer’s Report 2011 ‘The Benefits of Early Diagnosis and Intervention’, released today by Alzheimer’s Disease International (ADI), shows that there are interventions that are effective in the early stages of Alzheimer’s disease, some of which may be more effective when started earlier, and that there is a strong economic argument in favor of earlier diagnosis and timely intervention.

ADI commissioned a team of researchers led by Professor Martin Prince from King’s College London Institute of Psychiatry, to undertake the first-ever, comprehensive, systematic review of all evidence on early diagnosis and early intervention for dementia.

Currently, the majority of people with dementia receive a diagnosis late in the course of the disease, if at all, resulting in a substantial ‘treatment gap’. This greatly limits their access to valuable information, treatment, care, and support and compounds problems for all involved – patients, families, carers, communities and health professionals.

Lead author Prof Prince said: ‘There is no single way to close the treatment gap worldwide. What is clear is that every country needs a national dementia strategy that promotes early diagnosis and a continuum of care thereafter. Primary care services, specialist diagnostic and treatment centers and community-based services all have a part to play, but to differing degrees depending upon resources.’

‘Failure to diagnose Alzheimer’s in a timely manner represents a tragic missed opportunity to improve the quality of life for millions of people,’ said Dr. Daisy Acosta, Chairman of ADI. ‘It only adds to an already massive global health, social, and fiscal challenge – one we hope to see in the spotlight at next week’s United Nations Summit on Non-Communicable Diseases.’

The new ADI report reveals the following:

    * As many as three-quarters of the estimated 36 million people worldwide living with dementia have not been diagnosed and hence cannot benefit from treatment, information and care. In high-income countries, only 20-50% of dementia cases are recognized and documented in primary care. In low- and middle-income countries, this proportion could be as low as 10%.

    * Failure to diagnose often results from the false belief that dementia is a normal part of aging, and that nothing can be done to help. On the contrary, the new report finds that interventions can make a difference, even in the early stages of the illness.

    * Drugs and psychological interventions for people with early-stage dementia can improve cognition, independence, and quality of life. Support and counseling for caregivers can improve mood, reduce strain and delay institutionalization of people with dementia.

    * Governments, concerned about the rising costs of long-term care linked to dementia, should spend now to save later. Based on a review of economic analyses, the report estimates that earlier diagnosis could yield net savings of over US$10,000 per patient in high-income countries.

‘Over the past year, the research team has reviewed thousands of scientific studies detailing the impact of early diagnosis and treatment, and we have found evidence to suggest real benefits for patients and caregivers,’ said Marc Wortmann, Executive Director of ADI.

‘Earlier diagnosis can also transform the design and execution of clinical trials to test new treatments. But first we need to ensure that people have access to the effective interventions that are already proven and available, which means that health systems need to be prepared, trained and skilled to provide timely and accurate diagnoses, communicated sensitively, with appropriate support.’

To that end, ADI recommends that every country have a national Alzheimer’s/dementia strategy that promotes early diagnosis and intervention. More specifically, governments must:

    * Promote basic competency among physicians and other health care professionals in early detection of dementia in primary care services.

    * Where feasible, create networks of specialist diagnostic centers to confirm early-stage dementia diagnosis and formulate care management plans.

    * In resource-poor settings, apply the World Health Organization’s recently developed guidelines for diagnosis and initial management by non-specialist health workers.

    * Publicize the availability of evidence-based interventions that are effective in improving cognitive function, treating depression, improving caregiver mood and delaying institutionalization.

    * Increase investment in research–especially randomized control trials to test drugs earlier and over longer periods of time, and to test the efficacy of interventions with particular relevance to early-stage dementia.

On the Net:

Gene That Controls Chronic Pain is Identified

(Ivanhoe Newswire) — The possibility of developing a drug to combat chronic pain is within reach now that scientists have discovered the gene responsible for regulating chronic pain, called HCN2.

About 30 million Americans suffer from chronic, or long-lasting, pain of some kind. The most common sources of chronic pain are arthritis, back pain, and headaches. Chronic pain comes in two main varieties. The first, inflammatory pain, occurs when a persistent injury (e.g. a burn or arthritis) results in an enhanced sensitivity of pain-sensitive nerve endings, thus increasing the sensation of pain.

More intractable is a second variety of chronic pain, neuropathic pain, in which nerve damage causes on-going pain and a hypersensitivity to stimuli. Neuropathic pain, which is often lifelong, is a surprisingly common condition and is poorly treated by current drugs. Neuropathic pain is seen in patients with diabetes (affecting 3.7m patients in Europe, USA and Japan) and as a painful after-effect of shingles, as well as often being a consequence of cancer chemotherapy. Neuropathic pain is also a common component of lower back pain and other chronic painful conditions.

“Individuals suffering from neuropathic pain often have little or no respite because of the lack of effective medications. Our research lays the groundwork for the development of new drugs to treat chronic pain by blocking HCN2,” Professor Peter McNaughton, lead author of the study and Head of the Department of Pharmacology at the University of Cambridge, was quoted as saying.

The HCN2 gene, which is expressed in pain-sensitive nerve endings, has been known for several years, but its role in regulating pain was not understood. Because a related gene, HCN4, plays a critical role in controlling the frequency of electrical activity in the heart, the scientists suspected that HCN2 might in a similar way regulate the frequency of electrical activity in pain-sensitive nerves.

For the study, the researchers engineered the removal of the HCN2 gene from pain-sensitive nerves. They then carried out studies using electrical stimuli on these nerves in cell cultures to determine how their properties were altered by the removal of HCN2.

Following promising results from the in vitro studies in cell cultures, the researchers studied genetically modified mice in which the HCN2 gene had been deleted. By measuring the speed the mice withdrew from different types of painful stimuli, the scientists were able to determine that deleting the HCN2 gene abolished neuropathic pain. Interestingly, they found that deleting HCN2 does not affect normal acute pain (the type of pain produced by a sudden injury— such as biting one’s tongue).

“Many genes play a critical role in pain sensation, but in most cases interfering with them simply abolishes all pain, or even all sensation,” Professor McNaughton added. “What is exciting about the work on the HCN2 gene is that removing it – or blocking it pharmacologically- eliminates neuropathic pain without affecting normal acute pain. This finding could be very valuable clinically because normal pain sensation is essential for avoiding accidental damage.”

SOURCE: Science, published online September 9, 2011

Men Experience Hormone Changes After Marriage And Children

 

A new study by researchers at Northwestern University shows that fathers may be biologically wired to be more nurturing after marriage and children. The study is titled “Longitudinal Evidence That Fatherhood Decreases Testosterone in Human Males” was published in the September 12, 2011 issue of the Proceedings of the National Academy of Sciences (PNAS).

The study looked at 624 males aged 21.5 to 26 years old for 4.5 years in the Philippines. The researchers found that the men, before they were married, had normal levels of testosterone, the primary male sex hormone. After the men were married, the researchers found that the testosterone levels of the men had dropped, and when the man smelled his own child his testosterone level dropped even further.

Christopher W. Kuzawa, co-author of the study and associate professor of anthropology in the Weinberg College of Arts and Sciences said, “Humans are unusual among mammals in that our offspring are dependent upon older individuals for feeding and protection for more than a decade. Raising human offspring is such an effort that it is cooperative by necessity, and our study shows that human fathers are biologically wired to help with the job.”

According to the AFP, men who became fathers during the study showed a median 26 to 34 percent drop in testosterone levels, while the normal age-related drop in testosterone in single men who were not fathers was 12 to 14 percent. The steepest decline of the hormone was in fathers of newborns less than one month old.

Lee Gettler, a co-author of the study, says that “Fatherhood and the demands of having a newborn baby require many emotional, psychological and physical adjustments. Our study indicates that a man´s biology can change substantially to help meet those demands.”

Having lower testosterone levels may not be as bad as it sounds. According to the New York Times, some experts believe that the hormone study could offer new insight into men´s medical conditions, particularly prostate cancer. Higher levels of testosterone over a lifetime show an increase in a man´s risk of prostate cancer, much like a woman´s increase in estrogen levels shows an increase in breast cancer.

Dr. Peter Ellison, a professor of human evolutionary biology at Harvard, who was not involved in the study, told the New York Times, “Fathers who spend a lot of time in fathering roles might have lower long-term exposure to testosterone, reducing their risk.”

Men should be reassured though that these hormonal changes may be dramatic and not drastic. Dr. Carol Worthman, an anthropologist from Emory University also uninvolved with the study, told the New York Times, “If guys are worried about basically, ℠Am I going to remain a guy?´ We´re not talking about changes that are going to take testosterone outside the range of having hairy chests, deep voices and big muscles and sperm counts. These are more subtle effects.”

MSNBC notes that there is research done with primates that when they smell their own children their testosterone levels drop within minutes. This could be the body´s way of protecting the young by lowering aggressive behavior so the father doesn´t become rowdy and cruel around the kids and possibly attack them.

On the Net:

Psoriasis Patients Face Higher Than Average Death Risk After A Heart Attack

Research points to need for more aggressive approach to secondary prevention of cardiovascular disease in psoriasis patients

Heart attack patients with psoriasis are 26 per cent more likely to die from cardiovascular disease, or suffer from recurrent heart attacks or strokes, and are 18 per cent more likely to die from all causes than those without the inflammatory skin disease. That’s the key finding of a Danish study published in the September issue of the Journal of Internal Medicine.

Researchers studied nearly 50,000 patients who had experienced their first heart attack between 2002 and 2006, following the 462 patients with psoriasis for an average of 19.5 months and the 48,935 controls for an average of 22 months.

They found that the patients with psoriasis had higher all-cause and specific death rates and say this indicates the need for a more aggressive approach to secondary prevention of cardiovascular disease in this group of patients.

“Psoriasis is a common skin condition that is estimated to affect 125 million people worldwide” explains lead author and cardiologist Dr Ole Ahlehoff, from Copenhagen University Hospital Gentofte.

“It is a chronic inflammatory condition where the skin cells we naturally shed all the time are replaced much quicker than normal, leading to a build up of psoriatic plaque. Heart attacks are also caused by a build-up of plaque, in the arteries leading to the heart. Our study explored the links between the two conditions, which appear to have similar inflammatory mechanisms.”

Key finding of the study included:

    * The incidence rates per 1000 patient years for all-cause deaths were 16 per cent higher for those with psoriasis (138.3 versus 119.4) and the adjusted hazard ratio was 1.18 (18 per cent higher).

    * The incidence rates per 1000 patient years for deaths for a composite of cardiovascular death, recurrent heart attacks or stroke were 24 per cent higher for those with psoriasis (185.6 versus 149.7) and the adjusted hazard ratio was 1.26 (26 per cent higher).

    * Baseline measurements showed that patients with psoriasis had a higher rate of hospitalisation for stable and / or unstable angina (severe chest pain). They also showed that a higher percentage of patients with psoriasis were treated with statins and ACE inhibitors / angiotensin 2 receptor blockers.

    * Patients with psoriasis who survived their first heart attack were more likely to receive statin therapy than those without psoriasis. However the presence of other health issues, and the differences in clinical management, did not explain the worsened prognosis in patients with psoriasis.

“To our knowledge, this is the first study to assess the prognosis in patients with psoriasis following a heart attack” says Dr Ahlehoff. “Our findings show that people with psoriasis demonstrated a significantly increased risk of recurring adverse cardiovascular events and a trend for increased all-cause deaths after a heart attack.

“Furthermore, the poor prognosis faced by psoriasis patients who have had a heart attack suggests the need for a more aggressive approach to secondary prevention of cardiovascular disease in this group of patients.”

On the Net:

Some Cartoons Damage Kids’ Concentration And Self-Control

 

A new study, published by the journal Pediatrics today found that watching “fast-paced, fantastical” cartoon programming can be a detriment to the attention spans of 4-year-old children, however watching more realistic cartoons does not, MSNBC is reporting.

At 4 months of age, US children are already acclimated to regular viewing of daily television, and they watch lots of it, Dr. Dimitri Christakis writes in a commentary accompanying the study.

The American Academy of Pediatrics recommends that children under 2 years of age watch no television at all, the group says a limited amount is acceptable for older children as long as it´s no more than one to two hours a day of educational programs.

“It confirms something that parents have observed for some time,” Christakis says of the study. “They put their kids in front of television, particularly fast-paced programming, to quiet them down, but when the TV goes off, the kids are more amped up than they were before.”

Psychologists from the University of Virginia tested 4-year-old children immediately after they had watched nine minutes of the popular show “SpongeBob SquarePants”.

The study found that their ability to pay attention, solve problems and moderate behavior had been severely compromised compared to 4-year-olds who had either watched the slower-paced “Caillou,” a slower-paced, realistic public television show for nine minutes, or had spent nine minutes drawing.

“There was little difference on the tests between the drawing group and the group that watched ℠Caillou,´” said lead investigator Angeline Lillard, a psychology professor in U.Va.´s College of Arts & Sciences.

Lillard and her co-author, Jennifer Peterson, explain that 4-year-olds are in an important development stage of their lives and that what they watch on television may have lasting effects on their lifelong learning and behaviors. Their study, however, focused on the immediate effects.

“Young children are beginning to learn how to behave as well as how to learn,” Lillard said. “At school, they have to behave properly, they need to sit at a table and eat properly, they need to be respectful, and all of that requires executive functions. If a child has just watched a television show that has handicapped these abilities, we cannot expect the child to behave at their normal level in everyday situations.”

She emphasizes that parents should come up with creative learning activities, such as drawing, using building blocks and board games, and playing outdoors to help their children develop healthy social behaviors and learning skills.

“Executive function is extremely important to children´s success in school and in everyday life,” Lillard said. “It´s important to their psychological and physical well-being.”

Don´t blame Mr. SquarePants for messing with preschoolers´ brains, Nickelodeon spokesman David Bittler told MSNBC. “SpongeBob is produced for 6- to 11-year-olds. Four-year-olds are clearly not the intended demographic for this show.”

SpongeBob is not listed among the shows for preschoolers on nickjr.com, of which, the best-known of those is “Dora the Explorer,” Bittler says.  Many adults complain, however, that Dora is too slow, MSNBC reports.

SpongeBob might not have the same negative effect on attention in older children, the authors acknowledge. They don´t know how long the negative effects last or what the long-term effects of regularly viewing SpongeBob, Patrick, Squidward and the gang might be.

“Maybe the next step is really to try and figure out how long-lasting these effects are,” says Georgetown University psychologist Rachel Barr told MSNBC.

On the Net:

Critical Similarity Found Between Two Types Of Do-it-all Stem Cells

 
Ever since human induced pluripotent stem cells were first derived in 2007, scientists have wondered whether they were functionally equivalent to embryonic stem cells, which are sourced in early-stage embryos.
Both cell types have the ability to differentiate into any cell in the body, but their origins — in embryonic and adult tissue — suggest that they are not identical.
Although both cell types have great potential in basic biological research and in cell- and tissue-replacement therapy, the newer form, called IPS cells, have two advantages. They face less ethical constraint, as they do not require embryos. And they could be more useful in cell replacement therapies: growing them from the patient’s own cells would avoid immune rejection.
But until IPS cells are proven to have the same traits as embryonic stem cells, they cannot be considered to be identical.
In a study published Sunday, Sept. 11, researchers at the University of Wisconsin-Madison report the first full measurement of the proteins made by both types of stem cells. In a study that looked at four embryonic stem cells and four IPS cells, the proteins turned out to be 99 percent similar, says Joshua Coon, an associate professor of chemistry and biomolecular chemistry who directed the project.
“We looked at RNA, at proteins, and at structures on the proteins that help regulate their activity, and saw substantial similarity between the two stem-cell types,” he says.
Proteins are complex molecules made by cells for innumerable structural and chemical purposes, and the new study measured more than 6,000 individual proteins using highly accurate mass spectrometry, a technique that measures mass as the first step of identifying proteins.
The study in Nature Methods, published online, is the first comprehensive comparison of proteins in the two stem cell types, says Doug Phanstiel, who is now at Stanford University, and worked with Justin Brumbaugh on the project as graduate students at UW-Madison.
“From a biological standpoint, what is novel is that this is the first proteomic comparison of embryonic stem cells and IPS cells,” says Phanstiel, referring to the study of which proteins a cell produces.
In essence, every cell in the body has the genes to make any protein the body might need, but cells make only the proteins that further their own biological role. Cells regulate the formation and activity of proteins in three ways: first, by controlling the production of RNA, a molecule that transfers the DNA code to protein-making structures; second, by controlling the quantity of each protein made; and third, by adding structures to the protein that regulate when it will be active.
The new study measured each of these activities, Phanstiel says.
“And because we compared four lines of each type of stem cell, and the comparisons were run three times, the statistics are extremely robust,” he adds.
The new report, Coon says, suggests that embryonic stem cells and IPS cells are quite similar. According to some measurements, the protein production of an embryonic stem cell was closer to that of an IPS cell than to a second embryonic stem cell.
The ability to measure proteins in such detail emerged from improved ways to measure mass, Coon says.
“New technical developments in both our ability to measure a protein’s mass — accurate to the third or fourth decimal place — and to compare the proteins from up to eight different cell lines at a time — permitted this important comparison for the first time,” says Coon.
The study is not the last word in determining the similarity of the two types of pluripotent stem cells, says Coon, who worked with UW-Madison stem-cell pioneer James Thomson, on the project.
Because clinical uses of either type of stem cells will require that they be transformed into more specialized cells, researchers still need to know more about protein production after a stem cell is differentiated into, for example, a neuron or heart muscle cell.
This technology, Coon says, “is now well-positioned to study how closely molecules contained in these promising cells change after they are differentiated into the cells that do the work in our bodies — a critical next step in regenerative medicine.”

On the Net:

Grieving Linked to Life Expectancy in Parents

(Ivanhoe Newswire) – Losing a child, may also mean lower life expectancy for parents.  According to research, parents who lose their child during the first 12 months of life are at a significantly increased risk of an early death and the effect can last up to 25 years.

Researches looked at a random 5 percent sample of United Kingdom death registrations from the year 1971 to 2006 that included parents whose child had survived beyond the first year of life; those whose child had died before reaching a first birthday; and parents whose children had been stillborn.

The results showed that parents in Scotland were more than twice as likely to die or become widowed in the first 15 years after the loss of a child in the first year as those who had not been bereaved in this way.

Bereaved mothers were especially prone to an early death, the figures showed.

Bereaved mothers in England and Wales were more than four times as likely to die in the first 15 years after losing a child. Although the effects lessened gradually over time, they were still 1.5 times more likely to die than mothers who had not lost their child early, up to 25 years after the death.

According to the authors, “dying of a broken heart”, seems to also apply to losing a child in infancy, not just people who lose their spouse or partner, in which they often die earlier than expected.

The authors suggest that the stress of bereavement may affect the immune system by weakening it.

“Bereaved parents may also be more likely to use maladaptive coping strategies, such as alcohol misuse,” the authors were quoted saying, suggesting a higher risk for alcohol related illnesses or unintentional injuries.  Furthermore, the authors also suggest that stillbirth and infant deaths could be more common among parents with poor health.

“It is imperative that cause of death be further investigated in order to establish the factors leading to increased mortality in bereaved parents,” the authors were quoted saying.

SOURCE:  BMJ Supportive & Palliative Care, published online September 2011

Promising News for Heart Failure

(Ivanhoe Newswire) — Researchers have discovered a new drug target that they say may treat and/or prevent heart failure.

The team of scientists from Mount Sinai School of Medicine studied failing human and pig hearts. They discovered a protein known as SUMO1, which regulates the activity of key transporter genes, was decreased in failing hearts. Heart function was improved when the researchers injected SUMO1 into the hearts via gene therapy.

The investigators were evaluating the transporter gene SERCA2a in patients as part of a clinical trial. When delivered through an inactive virus that acts as a medical transporter into cardiac cells, SERCA2a demonstrated improvement or stabilization with few side effects. However, they found over time, the new SERCA2a became dysfunctional, suggesting that something else upstream from SERCA2a was causing the dysfunction in the heart.

The scientists identified SUMO1 as the regulator of SERCA2a, showing that it enhanced its function and improved its stability and enzyme activity. When SUMO1 decreased, SERCA2a became dysfunctional, showing that SUMO1 plays a protective role. When SUMO1 was injected as a gene therapy, it protected SERCA2a from the oxidative stresses and dysfunction that are present in heart failure.

“Our experiments over the last four years beginning with the discovery of SUMO1 as an interacting protein of SERCA2a have shown that it plays a critical role in the development of heart failure,” Roger J. Hajjar, M.D., Director of Mount Sinai’s Wiener Family Cardiovascular Research Laboratories, and the Arthur and Janet C. Ross Professor of Medicine, Mount Sinai School of Medicine, was quoted as saying. “In fact, SUMO1 may be a therapeutic target at the earliest signs of development, and may be beneficial in preventing its progression, a much-needed advance for the millions suffering from this disease.”

According to the U.S. Centers for Disease Control and Prevention, about 5.8 million Americans suffer from heart failure, and 670,000 new cases are diagnosed each year. One in five people who have heart failure die within one year of diagnosis.

SOURCE: Nature, September, 2011

Lack of Dopamine can lead to Parkinson’s

(Ivanhoe Newswire) — Dopamine is more than just for pleasure!  The lack of the brain chemical dopamine can rewire the interaction between two groups of brain cells and lead to symptoms of Parkinson´s disease.

The discovery, made by Anatol Kreitzer, PhD, a scientist at Gladstone Institute, identified how the loss of dopamine alters the wiring of a small group of brain cells, kicking off a chain of events that eventually leads to difficulties controlling movement–a hallmark of Parkinson´s disease.
More than a half-million people suffer from Parkinson´s in the United States, including the boxer Muhammad Ali and the actor Michael J. Fox.

“The development of truly effective and well-tolerated therapies for Parkinson´s has proved difficult,” Lennart Mucke, MD, director of neurological disease research at the Gladstone Institute and professor of neurology and neuroscience at the University of California,  San Francisco,  a Gladstone affiliate, was quoted as saying.  Dr. Mucke also added that he hopes the new discovery will lead to the development of more effect medicines.

To better understand Parkinson´s and the relationship between dopamine and medium spiny neurons, also known as MSNs that work together to coordinate body movement, , Dr. Kreitzer artificially removed dopamine from the brains of laboratory mice in which the mice began to experience motor symptoms of the disease, including tremors, problems with balance and slowed movement.

Not only did the decrease dopamine levels throw off the balance between the two types of MSNs, but they also changed the interaction between MSNs and another group of neurons called fast-spiking neurons, or FSNs.

Dr.Kreitzer´s experiments showed that under normal circumstances, FSNs connect to both types of MSNs in a similar way; however, without dopamine, the signaling between the FSN circuits gets rewired and the neurons begin to target one type of MSN over the other.

“Our research has uncovered how an entirely different group of neurons can play a role in the development of Parkinson´s disease symptoms,” Dr. Kreitzer, who is also an assistant professor of physiology and neurology at UCSF was quoted saying.  “We hope to target the changes among these neurons directly with drug therapies, in order to help relieve some of Parkinson´s most debilitating symptoms.”

SOURCE: Neuron, published online September 2011

New Evolutionary Link Between Australopiths And Humans

 

[ View Video]

New analysis of two-million-year-old hominid bones found in South Africa provide the clearest evidence of evolution´s first major step toward modern humans, evidence that is leading some experts to believe the findings will change longstanding views on the origins of humans.

The well-preserved bones, from Australopithecus sediba, are from a part-human, part-ape species that have never been seen before now. The hands are similar to man, it has sophisticated ankles that helped in movement, and a surprisingly tiny but advanced brain, according to a report released Thursday.

The fossils were discovered in a sunken cave north of Johannesburg. Lead researcher Lee R. Berger of the University of Witwatersrand in South Africa, said A. sediba is the most likely candidate to be the ancestor of modern humans.

“The many very advanced features found in the brain and body, and the earlier date make it possibly the best candidate ancestor for our genus, the genus Homo, more so than previous discoveries,” Berger said in a press release.

The bones were discovered in 2008 by Berger and his then 9-year-old son, Matthew. Matthew found the first bone that was determined to belong to a child. Two weeks later Berger uncovered the fossils of a female.

Berger and colleagues examined fossils from the site and said they found the most complete hand, the most complete, undistorted hip bone and well-preserved ankle bones.

“This is giving us insight, that isn’t guesswork into an area of anatomy that is crucial and critical in how human walking evolved,” Berger told Reuters reporter Jon Herskovitz in regards to the foot and ankle bones.

The hand, which had been described as a human-like at the end of an ape-like arm, had a precision grip that could have aided in making tools, research member Tracy Kivell, a researcher at Max Planck Institute in Germany, told Reuters.

The elongated thumb differs from that of apes and allows for it to grasp objects more firmly. The grapefruit-sized brain had a shape close to that of humans and may challenge theories about brain enlargement in human development, the researchers said.

The research, published in the journal Science in five segments (or papers), suggests that A. sediba was on a direct evolutionary line to Homo sapiens.

“We have examined the critical areas of anatomy that have been used consistently for identifying the uniqueness of human beings,” Berger told BBC News. “Any one of these features could have evolved separately, but it is highly unlikely that all of them would have evolved together if A. sediba was not related to our lineage.”

If the claim is proven to be correct, it would sideline nearly all other candidates in the fossil record for which similar assertions have been made.

Popular theory holds that modern humans can trace their lineage back to Homo erectus, which lived more than a million years ago. Many experts believe this animal may in turn have had its origins traced to more primitive hominids, such as Homo habilis and Homo rudolfensis.

The new evidence for A. sediba is that, although older than its “rivals,” some of its anatomy and capabilities were more advanced than these younger forms. Simply making it a more credible ancestor for H. erectus, Berger´s team claims.

The team identified the two individuals found as possibly a mother and son. They believe the two died together in some tragic accident that caused them to fall into the cave or to become trapped there. After death, their bodies were washed into a pool and became cemented in time along with the remains of several other animals.

“It’s as if evolution is caught in one vital moment, a stop-action snapshot of evolution in action,” Richard Potts, director of the human origins program at the Smithsonian Institution, who was not part of the research team, told Associated Press (AP) reporter Randolph E. Schmid.

Scientists have long considered that the Australopithecus family was a primitive candidate for human ancestry. And the new research seems to further establish that belief.

Scientists used dating technologies to find the age of the sediments encasing the recently discovered fossils. Original estimates placed the age of the remains at somewhere between 1.78 and 1.95 million years old. But the new measurements narrowed the window of uncertainty to just 3,000 years, bringing the age of the remains to between 1.977 and 1.98 million years old. The refined dating measurement is important, said the team, because it puts A. sediba deep enough in time to be a realistic ancestor of H. erectus.

“This is a very interesting time in human evolution because it is when we think we should be seeing the beginnings of our genus, Homo. Previously, we’ve had very few fossils from this time period, so the sediba fossils are remarkable in that they are so complete,” Dr. Robyn Pickering, from the University of Melbourne, Australia, who led the dating measurements, told BBC News.

Since the discovery of the site in August 2008, 220 bones have been found of the early hominins, representing at least five individuals. The new research is based on a detailed analysis of two of the individuals.

A total of five papers based on the new evidence are to be published in the prestigious journal Science on September 9, 2011. Four of the papers each reveal new evidence on the anatomy — including the skull, hand, foot and ankle, and pelvis — of early hominins based on the A. sediba fossils discovered. A fifth paper covers the most accurate dates ever achieved for early hominins in Africa.

Berger said A. sediba demonstrates a surprisingly unique combination of features, never before seen in an early human ancestor. “The many very advanced features found in the brain and body, and the earlier date make it possibly the best candidate ancestor for our genus, the genus Homo, more so than previous discoveries such as Homo habilis.”

Given the open access policy of Berger´s team, A. sediba is already one of the most studied hominin species yet discovered.

The team studying these fossils is one of the largest ever assembled in the history of archaeology or paleontology. With more than 80 scientists, students and technicians from around the world, the research team consists of geologists, computer specialists, functional morphologists, anatomists, and physicists, et. al. The papers mark one of the largest researches ever published by an African-based team or university, on a single subject to appear in a journal of this magnitude.

A high-resolution X-ray scan of the male specimen´s skull has produced a virtual cast of its braincase. The casting was made at the European Synchrotron Radiation Facility in Grenoble, France. Based on the cast, the researchers estimated an adult A. sediba´s brain would have been about 173 cubic inches in volume, or about the size of a medium grapefruit.

This is smaller than much older fossils in the record, such as the famous “Lucy” specimen, A. afarensis (3.2 million years old), but, the shape of the new measurement appears to be more human-like, especially at the front. This may hint at the start of the re-organization of the brain that would be necessary to make us what we are today.

“Indeed, one of our major discoveries is that the shape and form of sediba’s brain is not consistent with a model of gradual brain enlargement, which has been hypothesized previously for the transition from Australopithecus to Homo,” added Dr Kristian Carlson from the University of the Witwatersrand, one of the main authors of the paper.

Humans have a very large brain relative to their body size, nearly 4 times that of chimpanzees. Evolution from the brain of our shared ancestry with chimps has seen this radical size increase. However, the reconstructed endocast of the young male, was surprisingly small, only about 16 cubic inches larger than chimpanzees.

“The ESRF is the most powerful installation worldwide for scanning fossils, setting the standard for what can be achieved during non-destructive studies of internal structures of fossils,” noted Paul Tafforeau, staff scientist at the ESRF and a co-author of the paper.

The right-hand of the female is nearly complete. The team showed that it looks far more like a modern human hand than that from an ape. Its fingers are shorter relative to the thumb than in a chimpanzee. The hand appears to have possessed powerful muscles for grasping, suggesting A. sediba spent a lot of time in trees, moving from branch to branch. The team also argues that the hand shows dexterity capable of making simple tools.

The hand shows that major changes in the thumb usually associated with tool making “did not imply abandoning life in the trees.”

“In the foot article, we’re introduced to a unique and previously unknown combination of archaic and advanced traits in sediba,” explained Potts to the AP.

The fingers of A. sediba were curved, as might be seen in a creature that climbed and hung from trees. But they were also slim and the thumb was long. While the researchers feel the thumb shows capability of tool making, no tools were found at the digsite.

The fossil provides the first chance for researchers to evaluate the function of a full hand this old, said Kivell. Previously, hand bones older than Neanderthals have been isolated pieces rather than full sets. Hand bones from a single individual with a clear taxonomic affiliation are scarce in the hominin fossil record, which has hampered understanding of manipulative abilities of the hominid hand in the past.

The extraordinary manipulative skills of the human hand are viewed as a unique trait of humanity. Over the course of human evolution, the hand was freed from the constraints of locomotion and has evolved primarily for manipulation, including tool-use and eventually tool-production.

The researchers reconstructed the A. sediba hand then compared it with other hominin fossils and investigated the presence of several features that have been associated with human-like precision grip and the ability to make stone tools. They found that this early hand possessed many of these features, including the relatively long thumb compared to the fingers, longer than even that of modern humans.

The researchers said that A. sediba´s hand has more features related to tool-making than the 1.75-million-year-old “OH 7 hand” that was used to originally define the “handy man” species, H. habilis. However, A. sediba also retains morphology that suggests the hand was still capable of powerful flexion needed for climbing trees.

“Taken together, we conclude that mosaic morphology of Au. sediba had a hand still used for arboreal locomotion but was also capable of human-like precision grips,” said Kivell. “In comparison with the hand of Homo habilis, Au. sediba makes a better candidate for an early tool-making hominin hand and the condition from which the later Homo hand evolved.”

The ankle joint of A. sediba is mostly human-like in form and there is some evidence for a human-like arch and Achilles tendon. But sediba possessed an ape-like heel and lower shin bone. Though the heel bone seems primitive, the team found the front is angled. The researchers think this combination may have led to a distinctive type of walk when the creature was not climbing trees.

Whatever the correctness of the analysis, the creature did in fact have a fascinating mix of features — some archaic, some modern.

The pelvis is short and broad like a human pelvis, creating more of a bowl shape than in earlier Australopith fossils like the famous “Lucy,” explained Job Kibii of the University of the Witwatersrand.

A popular theory has been that the modern human pelvis evolved in tandem with the gradual growth in brain volume — facilitating the birth of babies with bigger heads. A. sediba possibly discredits this theory, said researchers, because it had a modern-looking pelvis while possessing a small brain.

That could force a re-evaluation of the process of evolution because many researchers had associated development of the pelvis with enlargement of the brain.

“It will take a lot of scrutiny of the papers and of the fossils by more and more researchers over the coming months and years, but these analyses could well be ℠game-changers´ in understanding human evolution,” Potts told the AP.

So, could this mean that A. sediba is the missing link?

Berger admits that scientists generally do not like that term, calling it “biologically unsound.”

A. sediba is a good candidate to represent the evolution of humans, he said, but the earliest definitive example of Homo is 150,000 to 200,000 years younger.

Scientists usually prefer the terms “transition form” or “intermediary form,” Darryl J. DeRuiter of Texas A&M University told the AP.

“This is what evolutionary theory would predict, this mixture of Australopithecine and Homo,” he said. “It’s strong confirmation of evolutionary theory.”

But it´s not yet an example of the genus Homo, DeRuiter said, though it could have led to several early human forms, including Homo habilis, Homo rudolfensis or Homo erectus – all considered early distant cousins to man, Homo sapiens.

“It’s a great find,” he adds, “because it provides strong confirmation for Darwin’s theories about evolution.”

This research forces “a rethinking of how traits are coupled together in human evolution,” Potts said in an email to AP’s Schmid.

“This isn’t the end of the story. What may be happening is that there were several australopithecine forms all evolving human-like features in parallel as they turned to meat-eating and tool-making and moving greater distances,” Stringer told BBC News.

“The question now is to pull out of this mess which one is really the ancestor of the genus Homo. We know there are more remains to come from this incredible site. Let’s see if other individuals also show this mix of features,” he concluded.

After the bones were discovered, the children of South Africa were invited by researchers to name the child, which they called “Karabo,” meaning ℠answer´ in the local Tswana language. The older specimen has not yet been given a nickname, said Berger.

The juvenile would have been aged 10 to 13 in terms of human development. The female was in her 20s and there are indications that she may have given birth one time. Researchers are not sure if the two were related. 

Image 1: The hand bones of an adult female Au. sediba as they were found in the matrix at Malapa, South Africa: An almost complete right hand was found clustered together with the rest of the upper limb. © Peter Schmid

Image 2: All of the right hand bones rearticulated. © Peter Schmid

Image 3: A 3-D rendering of the skull of Australopithecus sediba from an experiment at the ESRF beamline ID19. Credit ESRF/P. Tafforeau.

On the Net:

At 35-37 Weeks, Babies Distinguish Pain From Touch

 
Researchers using electroencephalography (EEG) recorded the brain activity of preemies in response to pain, comparing their pain responses from a touch or prick on the heels. The premature children responded to pain around a woman´s 35th week of pregnancy, about two to four weeks before delivery, according to a new study from University College London.
Dr. Rebeccah Slater, UCL Neuroscience, Physiology and Pharmacology, explained in a press release: “Premature babies who are younger than 35 weeks have similar brain responses when they experience touch or pain.”
“After this time there is a gradual change, rather than a sudden shift, when the brain starts to process the two types of stimuli in a distinct manner,” ABC News is reporting.
Children at more than 35 weeks´ gestation had a greater burst of activity in response to the lance than the simple touch. However babies, who were only 28 to 35 weeks in the womb showed the same brain activity for the touch and the heel lance.
These findings may explain why babies born prematurely have an abnormal sense of pain, and the findings could potentially affect treatment and care of preemies.
“Clinical practice changed about two decades or more ago to take into account the pain response of premature infants, and term infants,” Dr. Eliot Krane, a professor of anesthesia and pediatrics at Stanford University School of Medicine, told ABC’s GMA reporter Mikaela Conley. “Clinical practice continues to evolve as we become more cognizant of the deleterious effect of pain in infants.”
Fetal pain, an area that experts say is lacking in research because it is difficult to study, has often been a point of tension in the ever-controversial abortion debate. Over the past six years, six states have enacted fetal pain abortion bans in which it is illegal to perform an abortion after 20 weeks.
Many anti-abortion rights activists argue that fetuses can feel pain in the womb after 20 weeks of development. “The findings … should help inform the pain perception portion of the abortion debate,” Dr. F. Sessions Cole, director of the division of newborn medicine at Washington University School of Medicine at St. Louis, told ABC’s Conley.
“Although this study specifically addresses brain wave differences between premature and term infants, not fetuses, after [receiving] painful and tactile stimuli, it suggests that brain maturation required for fetal pain perception occurs in late pregnancy, more than 11 weeks after the legal limit for abortion in the United States.
“Although fetal pain perception is a complex phenomenon which we do not yet fully understand, this study raises the possibility that maternal pain relief during abortion may require administration of medications more than fetal pain relief,” Cole continued.
Results of teh study were published Spet. 8 in the Current Biology journal.

On the Net:

Hospital Records Posted Online In Security Breach

 

For nearly a year, medical records for twenty-thousand emergency room patients at a Palo Alto, California hospital were available online for public viewing. The breach included names of patients and diagnosis codes, the hospital has confirmed to the New York Times.

Although medical security breaches are not uncommon, the Stanford Hospital breach was notable for the length of time that the data remained publicly available without detection.

The hospital, since being made aware of the information leak, has been investigating how the detailed spreadsheet containing the information made its way from one of its vendors, to a web site called Student of Fortune, which allows students to solicit paid assistance with their schoolwork.

Gary Migdol, a spokesman for Stanford Hospital and Clinics, told the International Business Times that the spreadsheet first appeared on the site on in early September of last year, as an attachment to a question about how to convert the data into a bar graph.

Despite government regulations strengthening the requirement of public reporting of breaches and imposing heavy fines, experts on medical security said this latest breach highlights the increasing difficulty of keeping data secure while being shared by a growing number of subcontractors and systems.

The subcontractor of the vendor, Multi Specialties Collection Services, created the spreadsheet as part of a billing-and-payment analysis for Stanford, according to Migdol. The vendor did not return calls by deadline and the hospital has suspended business with the company upon learning of the breach, the Mercury Times reports.

Bryan S. Cline, a vice president with the Health Information Trust Alliance, a nonprofit company that establishes privacy guidelines for health providers, points out that paper records can be lost, stolen or insecurely disposed of. With medical records being moved into digital formats, large breaches are emerging as a growing problem, he told mercury News.

Vendors and subcontractors are common in the medical billing industry and many, “may not realize their obligations,” Cline added. While required to protect patient privacy under federal law, “they don´t understand the implications of that,” he said. “They may not even have a security person.”

The contracts that hospitals sign with vendors give them the right to recover any costs if records are breached. “But it hasn´t worked,” Cline told Mercury New reporter Lisa M. Krieger. “It´s a model based on trust — ℠I trust you to do the right thing because I can sue.´ There´s nothing about assuring that third parties can actually protect the information.”

Amber Yoo, spokeswoman for Privacy Rights Clearinghouse, a San Diego-based organization dedicated to protecting the privacy of American consumers, agreed. “A hospital may have trained all its staff, but the minute it leaves them and goes to a third party, they are giving away an element of control,” she told Krieger.

A health record is worth about $50 on the black market, compared to only $1 for a Social Security number, Cline said. It can be sold to people who lack health insurance and used to file fraudulent claims, he said.

“Any time you are putting sensitive information onto an electronic database, you are introducing risk,” Yoo said. And once records are online, “it is very hard to truly delete them. There are websites where you can look at archival versions of web pages.”

Americans expect doctors and hospitals to use their records only with consent, said Dr. Deborah C. Peel, founder of the watchdog group Patient Privacy Rights, “not to give them to legions of contractors and strangers. Existing regulations are just not strong enough to protect Americans´ sensitive health information. Today´s electronic health systems are not safe or trustworthy.”

Stanford notified affected patients within four days of the discovery and also arranged for free identity protection services.

On the Net:

Trans Fats From Ruminant Animals May Be Beneficial

 

A Canadian review, published in the latest edition of Advances In Nutrition suggests that trans fatty acids from ruminant animal sources, dairy, beef and lamb, may have beneficial health effects including reducing the risks of cardiovascular disease and cancer.

Dr. Spencer Proctor, one of the review authors and Director of the Metabolic and Cardiovascular Diseases Laboratory at the University of Alberta in Canada says, “The body of evidence clearly points to a change needed in how nutrition labels are handled. Right now in Canada and US a substantial portion of natural trans fats content is included in the nutrition label trans fats calculation, which is misleading for the consumer. We need a reset in our approach to reflect what the new science is telling us.”

The review notes that consumers are bombarded with information on what is healthy to eat and what is unhealthy. Fat is the usual target determining the healthiness of foods. But consumers are told that all trans fats are especially unhealthy.

The review noted that eating natural trans fats from animal sources had different bodily reactions than consuming the industrial trans fats, which are derived from hydrogenated oils and used to increase the shelf life of many manufactured food items.

According to the review, the industrial trans fatty acids have been shown to adversely affect multiple cardiovascular disease risk factors, including increasing concentrations of lipids, lipoproteins and inflammatory markers. But when patients in one study were given butter with high concentrations of ruminant trans fatty acid enriched with vaccenic acid (VA), the predominant trans monoene isomer in ruminant fats (50 – 80% total trans fat), plasma total cholesterol was reduced by 6% and high density lipoprotein cholesterol (HDL) was reduced by 9%, compared to the control butter that had a low concentration of VA.

Dr. Proctor was given a $1 million research grant by the Alberta Livestock and Meat Agency to further study these effects over the next several years. He said, “With industry, science, regulators and other important groups in this area working together, we can continue to make strides to help the public better understand the health implications of natural ruminant trans fats.”

On the Net:

GlobalSign Stops Issuing Authentication Certificates For Investigation

 
GlobalSign, a Belgian security firm, has stopped issuing authentication certificates for websites.
This move comes after an anonymous hacker claimed to have gained access to the company’s services.
If the attack is confirmed then it would be the second security breach at a European certificate authority in two months.
Comodohacker claimed responsibility for an attack on DigiNotar that saw hundreds of fake authentications issued.
Certificate authorities (CAs) are companies or public bodies whose job is to confirm that secure websites are genuine.
Once a computer connects to a site with TLS or SSL authentication, a certificate is issued that verifies the site’s identity to the web browser.
Comodohacker claimed to have gained access to four certificate authorities.
GlobalSign said it was temporarily ceasing the issuance of all certificates while it investigated the claims.
The hacker responsible for the DigiNotar hacks said it was for political reasons:  “Dutch government is paying what they did 16 years ago about Srebrenica, you don’t have any more e-Government huh?”
The reference is to the 1995 Srebrenica massacre where Serbian forces killed over 8,000 Bosnian Muslims.

On the Net:

One Drink A Day For Good Health?

 

New research shows that women who enjoy one alcoholic drink per day at midlife may be healthier in old age than women who do not drink at all, who consume more than two drinks per day, or who consume more than three drinks at one sitting.

The study, led by Qi Sun from the Harvard School of Public Health and the Brigham and Women´s Hospital in Boston, Mass, suggests that in women, regular alcohol consumption in moderation during middle age (average 58 years old) relates to good overall health — which translates to having no major chronic diseases or mental health impairments — in those who live beyond 70 years. The researchers define this good overall health as “successful ageing.”

The researchers report in the journal PLoS Medicine that this daily drink could be a pint of beer, a glass of wine or a single measure of spirit.

Sun and colleagues analyzed data from the Nurses´ Health Study, a long-running survey of registered nurses in the US. They compared their self-reported drinking in middle age with their health status at age 70. The study included nearly 14,000 women in all, beginning in 1976.

The study found that those who averaged between 3 and 15 alcoholic drinks per week — spread out evenly throughout the week — in their late 50s had up to 28 percent higher odds of being free of chronic illness, physical disability, mental health problems and cognitive decline at age 70. And women who drank on 5-7 days of the week had almost double the chance of good overall health in old age compared with those who abstained completely.

Experts are not sure whether it is the alcohol itself that is adds to the benefit or whether it simply goes hand in hand with other lifestyle choices that make women healthier.

Previous research has shown that alcohol can have a positive impact in the body, reducing insulin resistance, inflammation, high cholesterol and other harmful processes, when used in moderation.

However, drinking has also been linked to other conditions, such as breast cancer, but the findings do add to the “strong, consistent evidence” that people who drink in moderation are less likely than nondrinkers or heavy drinkers to experience many health problems, said Sun.

The team said the findings do not necessarily apply to men or to non-white women.

“These data suggest that regular, moderate consumption of alcohol at midlife may be related to a modest increase in overall health status among women who survive to older ages,” the authors wrote.

“The 2010 US Department of Agriculture dietary guidelines note that moderate alcohol consumption of up to one drink per day for women and up to two drinks per day for men may provide health benefits in some people. Our data support this recommendation and provide novel evidence suggesting that light-to-moderate alcohol consumption at the levels of one to two drinks/day or slightly less at midlife may benefit overall health at older ages in US women,” they added.

While the findings show that middle-aged women who drink moderately have increased odds of being healthier later in life, it doesn´t mean that women who do not currently drink should start. Other healthy habits, such as staying slim and exercising regularly, are far more important to overall health than alcohol consumption, added Sun.

“If you are physically active, if you have a healthy body weight at midlife, you can have much better odds of achieving successful aging,” he said. “You don’t have to use moderate alcohol consumption as a way to help achieve healthy aging.”

Plus, Arun Karlamangla, MD, an associate professor of geriatrics at UCLA’s David Geffen School of Medicine, told Health.com reporter Anne Harding that large questionnaire-based studies like this one have somewhat inherent limitations.

Unlike clinical trials that compare an active drug with placebos, studies like these cannot prove that alcohol has a direct effect on long-term health, said Karlamangla.

People who drink in moderation “look systematically different than those who…either binge drink or don’t drink,” says Karlamangla, who has researched alcohol consumption and disability but was not involved in the new study. And those subtle differences — which might include their social life, eating and exercise habits, and stress levels at home and on the job — may influence overall health independent of alcohol consumption, he added.

“Even if you buy the idea that alcohol is good for you, we really can’t tease out what aspect is good for you from a study like this,” said Karlamangla.

Sun said they took into account more than a dozen health and demographic factors that could influence both drinking and ageing (such as diet, smoking, educational achievement, and family history of disease), but it is still impossible that the moderate drinkers differed in key ways from their peers.

“Moderate amounts of alcohol may offer some protection against heart disease, especially for women who have gone through the menopause, but it’s very important not to go overboard,” Natasha Stewart of the British Heart Foundation told BBC News reporter Michelle Roberts.

“Drinking too much doesn’t offer any heart health protection at all and may actually lead to heart muscle damage, stroke and high blood pressure. And if you don’t already drink alcohol, there is certainly no need to start now,” she told Roberts. “Clearly there are much better ways to look after your heart than drinking alcohol, like eating a healthy, balanced diet, getting active and by not smoking.”

Women should be aware that even moderate drinking has been linked to increased risk of breast cancer, said Sun. Although, he did add that this and other studies suggest that the health benefits of having one drink or less per day seem to outweigh the increase in the risk of breast cancer.

Karlamangla said the study was “well-done,” and despite the built-in limitations in the research, it reinforces the evidence moderate drinking has on healthy living. “I think there’s enough data to say that drinking a small glass of wine a day is good for you,” he remarked.

On the Net:

Looking For The Roots Of Racial Bias In Delivery Of Health Care

Johns Hopkins study suggests medical students may “learn” to treat nonwhite patients differently than white patients

New Johns Hopkins research shows that medical students – just like the general American population – may have unconscious if not overt preferences for white people, but this innate bias does not appear to translate into different or lesser health care of other races.

The research findings, published in the Sept. 7 issue of the Journal of the American Medical Association, questions whether something could be happening during medical training that turns benign unconscious preferences of students into ideas and behaviors that may lead to different types care for patients of different races.

Being a member of a minority race and being poor are consistent predictors of worse health outcomes in the United States, the investigators say, and substantial amounts of research suggest that racial bias – conscious or not – is an important factor in clinical decisions that create racial disparities in health care.

“Our results raise the question: Are we doing something in medical education and training that makes doctors act on their unconscious preferences, even though as medical students they may not have done so?” says study leader Adil H. Haider, M.D., M.P.H., an assistant professor of surgery at the Johns Hopkins University School of Medicine. “This may sound like a cliché, but I really do believe that most people who become doctors choose to do so out of a noble calling and they really want to help people. But it may be that training and experience are unwittingly reinforcing negative stereotypes pushing us to unconsciously treat some patients differently. If this is the case, it makes a good argument for interventions to ensure that doctors are aware of how even subtle biases may affect their decision-making and their assessments of patients.”

Previous studies using a validated “association test,” for example, have shown that roughly 70 percent of the general population, as well as doctors specifically, have an implicit preference for white people. One study showed that a group of doctors who were unconsciously partial to white people were less likely to treat black heart patients with needed clot-busting drugs and more likely to give them to similar white patients.

Other past studies have shown that among trauma patients, race and insurance status are independently associated with higher mortality. Minorities are less likely to undergo bypass surgery and are less likely to receive kidney dialysis or transplants, and more likely to undergo less-desirable procedures, such as lower limb amputations for diabetes. Several studies have shown that physicians prescribe fewer analgesics for African-Americans in emergency rooms despite similar estimates of pain.

In the new study, Haider and his team invited first-year Johns Hopkins medical students to participate in a confidential, Web-based survey. They were not informed of the survey content ahead of time and were asked not to share it with their peers afterward.

First, the students were given four clinical scenarios in which they were randomly presented with either a black or white patient and asked questions about how they would treat each. Next the students were presented with four more patients, this time randomly altering the patients’ social class, by incorporating occupations into the clinical vignettes.

To determine whether student assessment’s were associated with their unconscious attitudes, they were then given the Implicit Association Test (IAT) which is a widely used and validated tool that tests reaction times to uncover unconscious biases and preferences. For example, in the Black/White Race IAT, a photo of a white or black individual is presented along with words that have good and bad connotations. The test measures how quickly the participant associates good or bad words with people from each race. If a participant is quicker at associating the good words with a particular race, then that person is thought to have an unconscious preference towards that race. Haider and his team also used a new tool they developed, based on the IAT, to measure preferences for different social classes.

The research team found that of the 202 first-year medical students who participated, the IAT determined that 69 percent had an unconscious bias toward whites and 14 percent innately favored blacks. They also determined that 86 percent of the students had subconsciously favored upper class people, while just three percent showed a preference for those of a lower class.

To their surprise, and considering results of previous studies of practicing physicians, the researchers say they found that the unconscious preferences of students did not affect how they assessed or treated patients of various races and incomes depicted in the scenarios.

“For the most part, the students’ answers had nothing to do with the patients’ race or social class, regardless of their unconscious biases,” Haider says.

Haider says it is possible that the biases of younger people don’t affect their work because they may have been exposed to educational curricula focused on cultural competency, something that may translate into improved awareness and management of unconscious preferences.

Understanding – and confronting – the role that racial and social bias may play in the relationship between doctors and their patients is an important step toward fixing the racial disparities that plague the health care system, Haider says.

“We know there are disparities – they are well documented – but we need to confront them and understand why,” says Haider, who is also co-director of the Johns Hopkins Center for Surgery Trials and Outcomes Research. “Even though it’s a sensitive topic, we can’t move forward until we acknowledge the problem. We need to have an honest discussion about these things instead of just trying to ignore them or pretend they’re not there.”

On the Net:

Neutrinos: Ghostly Particles With Unstable Egos

They were always mysterious. 26 years had to pass before the prediction of theoretical physics was confirmed and the existence of neutrinos was finally proven experimentally in 1956. The reason for this ordeal: Neutrinos only interact by the weak interaction with other particles of matter. When a cosmic neutrino approaches the earth, it has the best chance of passing through the whole globe unhindered. It is correspondingly difficult to find direct evidence of neutrinos with the help of a detector. Further decades passed in the discussion about their masses: None or small but finite mass? In the meantime it is considered certain that the ghostly particles are carrying mass, if only a virtually infinitesimal amount: According to today’s knowledge, no neutrino should exist that is heavier than 1 eV (an electron “weighs” about 500,000 eV!). There are three types of neutrinos. This is also believed to be true today, so that neutrinos can each easily be classified in one of the three particle families in the framework of the standard model.
The knowledge of the neutrino mass is based on numerous experiments, in which so-called neutrino oscillations were observed. Neutrinos freely flying through the space of a particular family (i.e. the electron neutrino) can transform themselves spontaneously into a neutrino of another family affiliation (the muon neutrino or tau neutrino). One refers to an oscillation because the neutrino may change its family affiliation periodically during an extended journey. Such oscillations are only possible if the particles are carrying mass. The experimental evidence of neutrino oscillations (and thus a neutrino mass other than zero) is among the greatest breakthroughs of modern particle physics in the past 20 years.
The conversion process among different neutrino flavors depends on three so-called mixing angles Theta 12, Theta 23 and Theta 13. In interplay with the neutrino mass-squared differences they regulate the transition probabilities among different flavors. Of the three mixing angles only two are well known and have large values, while the third one Theta 13 is at the focus of current searches. So far, it was known that its value had to be small compared to the other two neutrino mixing angles. That is, Theta 13 = 0 could not be excluded. In the past, several independent projects have tried to measure this elusive parameter without success. The most important piece of information came in 1998 from the Chooz experiment in France, which established that the oscillation evoked by Theta 13 cannot be larger than approximately one tenth of those induced by the each of the other two neutrino mixing angles.
Three years ago a group of theoretical physicists of whom one, Antonio Palazzo, is now at the Excellence Cluster Universe, the others at the University and INFN of Bari, evidenced for the first time a weak hint of non-zero Theta 13 thanks to an accurate work of global analysis of all the existing neutrino oscillation data. In the meantime, two accelerator experiments (MINOS and T2K) were at work to nailing down Theta 13 and they have recently released their results. Notably, both experiments point towards a non-zero Theta 13, in agreement with the hint evidenced by the group of theorists. By combining their previous findings with the new accelerator data, in June 2011 the same group came for the first time to a statistically clear conclusion according to which sin² Theta 13 ≈ 0.02 with a confidence level of at least 3 Sigma. This means that the odds against Theta 13 > zero are 1:400.
However, physicists are very prudent and, before claiming a discovery, need to have a higher confidence level of 5 Sigma, diminishing the odds against Theta 13 > zero to 1:1 million. In order to provide secure evidence, the researchers are performing other experiments. Among these, the reactor experiment Double-Chooz, in which physicists of the Universe Clusters are strongly involved, will have a crucial role. For this purpose, it has been developed a particularly effective, terrestrial neutrino source: The particles (more precisely: anti-neutrinos) are generated and emitted during the fission processes in a nuclear power plant in particularly high flux. About 1020 antineutrinos leave a typical reactor every second. For this reason, a new experiment, the inheritor of the forerunning Chooz experiment, has started in the vicinity of the nuclear power plant in the French municipality Chooz. Thanks to this setup the value of Theta 13 will be measured with a precision that hitherto has not been achieved.
The principle behind the Double-Chooz experiment is very simple: Immediately after their generation in the reactor, several anti-neutrinos collide with a detector located 400 meters away. The spatial proximity ensures that no oscillations (or only extremely few) occur between emission and initial detection. The first detector thus measures the electron anti-neutrinos, which haven’t transformed to muon and or tau neutrinos yet. A second detector of identical construction is located approximately 1,050 meters away from the reactor. If the value of the neutrino mixing angle Theta 13 is large enough, a part of the electron anti-neutrinos will become muon or tau anti-neutrinos as a result of the oscillations. The electron-anti-neutrino rate observed at the second detector therefore is much smaller than expected without oscillations.
Both detectors are filled with about 10 tons of scintillation fluid. If an electron-anti-neutrino interacts with a proton within the fluid, this will lead to inverse-beta decay: The proton captures the electron-anti-neutrino thereby transforming into one neutron by emitting one positron. Both particles generate one quick flash each in the liquid in a set time sequence. 390 photo sensors mounted on the walls of the vessel record the events. The Double Chooz experiment started physics data taking in April 2011 and will search for corresponding signals for five years. The detector performance and the status of data taking will be reported at the TAUP conference in Munich from 5 to 9 September 2011. First results are expected by the end of this year.
Establishing that Theta 13 is effectively different from zero would entail that all the three mixing angles are non-vanishing. This would provide the three neutrino flavors with maximal freedom of flipping one to each other. In turn, such a high degree of freedom is the necessary condition to generate CP-violation in the leptonic sector, i.e. to give rise to a different behavior of neutrinos and anti-neutrinos. The observation of CP-violation is now the next target of neutrino physicists as it would have significant consequences for several unanswered questions of modern physics. It could soon be clarified, in particular, whether neutrinos were responsible for the minimal surplus of matter compared to anti-matter in the early Universe. Without this asymmetry, all matter would have been transformed to radiation shortly after the birth of the Universe. There would be no galaxies, no stars or planets and no one who could measure Theta 13.

On the Net:

Scientists Announce Breakthroughs In Fight Against Leukemia

 

Two new studies that could ultimately help with the diagnosis and treatment of leukemia were published in the Sunday edition of the journal Nature Genetics.

In the first, a team of scientists from the Center for Cancer Biology (CCB) at the University of Australia and the University of Washington discovered a genetic defect that they says indicates a pre-disposition to contract acute myeloid leukemia and myelodysplasia.

According to a University of Washington press release, those mutations were discovered in the GATA2 gene, which they say acts as a “master control” in the formation of white blood cells.

Leading the research were Dr. Hamish Scott and Dr. Richard J. D’Andrea at the University of Australia, and Dr. Marshall Horwitz, a professor of pathology and a genetic medicine practitioner at the UW Medical Center in Seattle.

According to the press release, “The genetic mutation was first discovered in a patient from central Washington. The research participant had been successfully treated for leukemia in 1992 through a bone marrow transplant at UW Medical Center. At that time, Horwitz decided to seek a possible genetic reason after learning his patient had several family members with myelodysplastic syndrome, myeloid leukemia, and intractable mycobacteria infections.”

“Horwitz’s Australian colleagues had described a family with a similarly inherited blood disorder,” it added. “Eighteen years later, after rifling through many candidate genes, the researchers on both continents were relieved finally to have hit upon the mutated gene responsible for the leukemia that affect these families.”

They discovered the abnormal GATA2 genes in more than 20 patients and/or families, the researchers said, leading them to declare that the condition was “more common than we had though.”

The scientists are now trying to determine why gene mutations in GATA2 cause these types of health problems, and according to the press release, they believe that “additional knowledge about how the GATA2 gene and its mutations operate may foster the development of new therapeutic agents.”

The second study, which was led by researchers João T. Barata at Instituto de Medicina Molecular in Lisbon, Portugal and J. Andres Yunes at Centro Infantil Boldrini in Campinas, São Paulo, Brazil, reported detecting mutations in T-cell acute lymphoblastic leukemia (T-ALL).

According to an Instituto de Medicina Molecular press release, the scientists discovered that these mutations allowed the cells to be eliminated through the use of “certain drugs, already in clinical use to treat other diseases.”

“The identification and study of mutations found in leukemia patients is particularly important to help develop more efficient and targeted therapies,” representatives from the institute said in that statement. “Researchers now found a group of mutations that affect 9% of the patients with T-ALL and that may originate leukemia in these patients“¦ Most importantly, researchers demonstrated that a set of pharmaceutical drugs can eliminate the effect of these mutations, unraveling a potential therapeutic application for their discovery.”

These mutations reportedly occur in the gene coding of the interleukin-7 receptor (IL7R), a protein located on the surface of T-cells. IL7R is used to transmit chemical information from the outside of the cell to the inside.

According to the press release, the researchers in this study discovered “that the mutations promote non-stop, uncontrolled T-cell proliferation, independently of extracellular triggers. This capacity to induce cells to grow relentlessly is associated with the ability to originate tumors.”

In order to combat these mutations, the scientists looked at drugs which are currently used to treat rheumatoid arthritis, and apparently can stop the cell proliferation in the mutated cells and wipe them out.

“We discovered that the interleukin-7 receptor, which is essential for proper T-cell development, may also have a ‘dark side’ “¦ In particular, we found that certain mutations in this gene are involved in pediatric T-cell acute lymphoblastic leukemia and characterized how they act,” Barata said in a statement.

“Our observations allowed us to identify potential therapeutic weapons against these tumors,” he added. “Although pediatric acute lymphoblastic leukemia is among the success stories in cancer therapy, improvements are still needed. We hope our findings will help further increase the efficacy and selectivity of already existing treatments.”

On the Net:

Scientists Produce Stem Cells Of Endangered Species

 

In what BBC News Environmental Correspondent Richard Black has called, “a novel marriage of conservation and modern biology,” researchers have successfully produced stem cells from a pair of endangered species.

Researchers from The Scripps Research Institute, who detail their work in an advance online edition of the journal Nature Methods on September 4, 2011, started with normal skin cells from the a west African monkey called the drill and the northern white rhino.

They were able to use a “re-programming” process, Black said, which involves the use of “retroviruses and other tools of modern cell biology” in order to “bring the cells back to an earlier stage of their development.” In that state, the cells are said to be pluripotent, meaning that they can be turned into a wide variety of different cell types, the BBC News reporter added.

The team, including San Diego Zoo Institute for Conservation Research Director Oliver Ryder and Scripps Research Professor of Developmental Neurobiology Jeanne Loring, began their work approximately five years ago, the institute said in a September 4 press release.

The hope was that they would be able to use stem cells from endangered species to save lives, the same way that scientists have been able to use these cells to treat humans with a variety of conditions.

It was Ryder who suggested using the drill and the northern white rhinoceros.

The drill was selected because of its close genetic connection to humans, and because in captivity the animals often suffer from diabetes, which researchers are working to treat in humans using stem cell-based therapies.

The rhinoceros was chosen because it is one of the most endangered animal species in the world, and because of the vast genetic differences between it and primates like the drill.

“After a year of trial and error, the researchers found that the same genes that induce pluripotency in humans also worked for the drill and the rhino…The process is inefficient, meaning only a few stem cells are produced at a time, but that’s enough,” representatives from the Scripps Institute said in their press release.

“The scientists view their success as a first step toward greater advancements,” they added. “Besides the possibility of using stem cells as the basis for diabetes or other treatments, there is great potential for new reproductive technologies as the stem cell research field advances.”

Image 1: Northern White Rhinoceros; Photo credit: San Diego Zoo

Image 2: Drill primate; Photo credit: San Diego Zoo

On the Net:

Rates Of Stroke In Young Adults On Rise

 
Unhealthy lifestyle choices are believed to be the reason for an increase of strokes that are affecting a younger-trending demographic is the US, BBC News is reporting.
Hospital discharge data on up to eight million patients per year between 1995 and 2008 was used to identify patients hospitalized for ischemic stroke. Researchers at the US Centers for Disease Control and Prevention (CDC), report in the Annals of Neurology that stroke rates in 15 to 44-year-olds rose by about a third in under 10 years.
“We identified significant increasing trends in ischemic stroke hospitalizations among adolescents and young adults,” said Mary George, M.D., M.S.P.H., lead author of the study and a medical officer with CDC´s Division for Heart Disease and Stroke Prevention.
“Our results from national surveillance data accentuate the need for public health initiatives to reduce the prevalence of risk factors for stroke among adolescents and young adults. Urgent public health initiatives are needed to reverse trends in modifiable risk factors associated with stroke in adolescents and young adults.”
The report continues by saying the prevalence of hypertension, obesity and tobacco use had increased in stroke patients and more than half of 35 to 44-year-olds who had an ischemic stroke also had hypertension.
Dr. Lorna Layward, from the Stroke Association in the UK, explained to BBC News, “People usually associate strokes with older people, but a quarter of all strokes happen to people of working age, and around 400 children have a stroke every year in the UK.”
“We know that high blood pressure is the biggest risk factor for stroke, along with other factors such as obesity, diabetes, poor diet and smoking. This research emphasizes the need for people to be aware that stroke can affect younger people, and for all of us, regardless of our age, to check our blood pressure and adopt a healthy lifestyle.”
The authors advised that adolescents, their guardians, and young adults can help avoid stroke by preventing and controlling hypertension, diabetes, and cholesterol by eating plenty of fresh fruits, vegetables and foods low in sodium and saturated fat. Maintaining a healthy weight, engaging in regular physical activity; and smoking cessation is also strongly recommended.

On the Net:

Undetected Lesions Could Cause Symptoms of Old Age

 

Tiny, blocked blood vessels in the brain, undetectable by modern-day technology, could be to blame for tremors, slower walking and changes in posture typically associated with aging, researchers at the Rush University Medical Center in Chicago have discovered.

Reporting their findings in the American Heart Association journal Stroke, lead author Aron S. Buchman and colleagues analyzed brain autopsies of more than 400 nuns and priests, who died at an average age of 88 and had donated their brains for post-mortem examination in 1994, according to a September 1 U.S. News and World Report article.

Buchman and his team discovered that 30% of them had microscopic brain lesions or infarcts that had not been diagnoses. Furthermore, they found that those who had the most trouble walking had multiple such lesions, and discovered that two-thirds of them “had at least one blood vessel abnormality, suggesting a possible link between the blocked vessels and the familiar signs of aging,” the American Heart Association said in a Thursday press release.

The lesions could not be detected using current scans, they said.

“This is very surprising,” Buchman, and associate professor of neurological sciences at the university, said in a statement. “There is a very big public health consequence because we’re not capturing this 30 percent who have undiagnosed small vessel disease that is not picked up by current technology. How would you even get them on your radar? We need additional tools in our toolkit.”

“Often the mild motor symptoms are considered an expected part of aging,” he added. “We should not accept this as normal aging. We should try to fix it and understand it. If there is an underlying cause, we can intervene and perhaps lessen the impact.”

Along with Buchman, co-authors of the study include Dr. Sue E. Leurgans, Dr. Sukriti Nag, Dr. David A. Bennett, and Dr. Julie A. Schneider, all of whom are also affiliated with Rush University Medical Center. The study was funded by The National Institutes of Health (NIH) and the Illinois Department of Public Health (IDPH).

On the Net:

Possible Genetic Cause Of Myopia Discovered

 

Researchers at a university in Israel claim to have discovered the genetic defect that results in myopia, more commonly known as nearsightedness.

A team of scientists from Ben-Gurion University of the Negev (BGU), led by Professor Ohad Birk, report that they discovered a mutation occurring in LEPREL1, a protein-coding gene type, “specifically causes myopia,” according to a Thursday press release from the school.

The research was completed at BGU’s Morris Kahn Laboratory of Human Genetics at the National Institute for Biotechnology in the Negev and the Dayan Clinical Genetics Wing at Soroka University Medical Center, and was detailed in an article published in the September 1 edition of the American Journal of Human Genetics (AJHG).

“We are finally beginning to understand at a molecular level why nearsightedness occurs,” Birk said in a statement.

Referred to in the BGU release as “the most common human eye disorder” and “a significant public health concern,” nearsightedness was linked to the defective LEPREL1 gene as part of a “thorough study of severe early-onset myopia that is common in a specific Bedouin tribe in southern Israel.”

“The gene, LEPREL1, encodes an enzyme that is essential for the final modification of collagen in the eye,” the university said. “In the absence of the active form of this enzyme, aberrant collagen is formed, causing the human eyeball to be longer than normal. As a consequence, light beams entering the eyeball focus in front of the retina rather than on the retina itself and myopia emerges.”

“As part of the research and in collaboration with a Finnish group, studies in a model system using insect cells demonstrated that the mutation is detrimental to the enzymatic activity of the gene,” they added.

Birk’s team, who worked alongside a group of researchers from Finland on the project, plan to conduct future studies to determine whether or not this gene, or others similar to LEPREL1, play a “significant” role in causing nearsightedness “in the population at large.” Their findings could lead to improved screening and prevention for the eye condition, they claim.

On the Net:

Half of Americans Drink Sugary Drinks Daily

 

According to a new Center for Disease Control and Prevention (CDC) report, nearly half of the US population consumes sugar drinks on any given day, with teenagers consuming more sugar drinks than any other age group.

The drinks the CDC considers sugar drinks are fruit drinks, sodas, energy drinks, sports drinks, and sweetened bottled waters. Sugar drinks do not include diet drinks, 100% fruit juice, sweetened teas and flavored milks.

According to the CDC report, males drink on average 175 kcal from sugar drinks on any given day, while females consume 94 Kcal. The report shows that males consume more sweet beverages except in the 2-5 year old category.

Consumption of the beverages peaks in the 12-19 year old demographic and then declines into old age. The group with the highest consumption of sweet beverages is the 12-19 year old males who consume 273 kcal per day, while the group with the lowest consumption rate is the oldest females in the 60 and over category, with a consumption of 42 kcal daily.

The CDC report indicates that there are racial differences in the consumption habits of sugary drinks. The data shows that non-Hispanic black children consume 8.5% of their diet in sweet beverages, while non-Hispanic whites consume 7.7% and Mexican American consume 7.4%.

In the 20 and over category, non-Hispanic blacks again lead in daily consumption with 8.6% of their daily dietary intake as sugary beverages while Mexican American´s consume 8.2% and Non-Hispanic Whites only consume 5.3% of their daily dietary intake as sugary drinks.

In response to the report, some cities are encouraging their citizens to decrease their consumption of sugary drinks. According to Reuters, the city health departments from Los Angeles, Boston, Philadelphia, San Antonio and Seattle announced plans for a campaign to encourage cutting down on sugary beverages.

Michael Jacobson, executive director of the nonprofit Center for Science in the Public Interest (CSPI) told Reuters, “We´re concerned about sugary drinks because they are the only foods and beverages that have directly been linked to obesity…Reducing their consumption is the perfect place to start to reduce the epidemic.”

The American Beverage Association, in dispute of the report´s findings told ABC News, “Contrary to what may be implied by the introductory statement of this data brief that reaches back 30 years, sugar-sweetened beverages are not driving health issues like obesity. According to an analysis of federal government data presented to the 2010 Dietary Guidelines, all sugar-sweetened beverages…account for only 7 percent of the calories in the average American´s diet.”

On the Net: